52
Drage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije sa međunarodnim učešćem u Beogradu. Kongres se održava u organizaciji Farmaceutskog društva Srbije i saradnji sa Farmaceutskim fakultetom Univerziteta u Beogradu, Farmaceutskom Komorom Srbije i Agencijom za lekove i medicinska sredstva Srbije. Zadovoljstvo nam je da su se pozivu odazvali istaknuti stručnjaci iz zemlje i inostranstva, kao i predstavnici farmaceutskih i srodnih fakulteta, farmaceutske industrije i međunarodnih stručnih udruženja. Učestvovanje je prijavilo više od 1500 farmaceuta i stručnjaka iz srodnih profesija, iz 14 zemalja. Naučni rad na Kongresu odvijaće se u okviru plenarnih predavanja, 11 uvodnih sekcijskih predavanja, 13 predavanja po pozivu, 33 usmena izlaganja, više od 220 poster prezentacija, tri mini simpozijuma, dve panel diskusije i okruglog stola. Verujemo da će Kongres pružiti priliku za sticanje novih znanja u farmaceutskim naukama i farmaceutskoj praksi, i omogućiti dragocenu razmenu iskustva sa kolegama iz inostranstva u cilju unapređenja kompetentnosti. Takođe, iskreno se nadamo da ćete uživati u lepoti oktobarskih dana u Beogradu. Želimo Vam uspešan rad i prijatan boravak. Dear colleagues and friends, It is our great pleasure and privilege to welcome you at the Fifth Congress of pharmacist of Serbia with international participation in Belgrade. The Congress is organized by Pharmaceutical Society of Serbia in collaboration with Faculty of Pharmacy, University of Belgrade, Pharmaceutical Chamber of Serbia and Agency for Medicinal Products and Medical Devices of Serbia. We are glad that our invitation has been accepted by outstanding specialists from Serbia and abroad, leading colleagues from pharmaceutical and related faculties, pharmaceutical industry and international professional organization. More than 1500 pharmacists and specialists from related professions, from 14 countries have been registered. Scientific work at the Congress is held as plenary lecture, 11 introductory lectures within sections, 33 oral presentations, more than 220 poster presentations, three mini symposiums, two panel discussions and the round table. We believe the Congress will provide you with the opportunity to be updated on the advances of the pharmaceutical science and innovative pharmacy practice. It will also provide you with a beneficial exchange of international experiences in order to advance competencies. Also, we sincerely hope you will enjoy your stay and Octobers days in Belgrade. We wish you success in your work and pleasant stay. Prof. dr Ivanka Miletić Predsednik Organizacionog Odbora President of Organizing Committee Prof. dr Branislava Miljković Predsednik Naučnog Odbora President of Scientific Committee

Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Embed Size (px)

Citation preview

Page 1: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Drage koleginice i kolege,dragi prijatelji,

Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije sa međunarodnim učešćem u Beogradu. Kongres se održava u organizaciji Farmaceutskog društva Srbije i saradnji sa Farmaceutskim fakultetom Univerziteta u Beogradu, Farmaceutskom Komorom Srbije i Agencijom za lekove i medicinska sredstva Srbije. Zadovoljstvo nam je da su se pozivu odazvali istaknuti stručnjaci iz zemlje i inostranstva, kao i predstavnici farmaceutskih i srodnih fakulteta, farmaceutske industrije i međunarodnih stručnih udruženja. Učestvovanje je prijavilo više od 1500 farmaceuta i stručnjaka iz srodnih profesija, iz 14 zemalja.Naučni rad na Kongresu odvijaće se u okviru plenarnih predavanja, 11 uvodnih sekcijskih predavanja, 13 predavanja po pozivu, 33 usmena izlaganja, više od 220 poster prezentacija, tri mini simpozijuma, dve panel diskusije i okruglog stola. Verujemo da će Kongres pružiti priliku za sticanje novih znanja u farmaceutskim naukama i farmaceutskoj praksi, i omogućiti dragocenu razmenu iskustva sa kolegama iz inostranstva u cilju unapređenja kompetentnosti.

Takođe, iskreno se nadamo da ćete uživati u lepoti oktobarskih dana u Beogradu.

Želimo Vam uspešan rad i prijatan boravak.

Dear colleagues and friends,

It is our great pleasure and privilege to welcome you at the Fifth Congress of pharmacist of Serbia with international participation in Belgrade. The Congress is organized by Pharmaceutical Society of Serbia in collaboration with Faculty of Pharmacy, University of Belgrade, Pharmaceutical Chamber of Serbia and Agency for Medicinal Products and Medical Devices of Serbia.We are glad that our invitation has been accepted by outstanding specialists from Serbia and abroad, leading colleagues from pharmaceutical and related faculties, pharmaceutical industry and international professional organization. More than 1500 pharmacists and specialists from related professions, from 14 countries have been registered.Scientific work at the Congress is held as plenary lecture, 11 introductory lectures within sections, 33 oral presentations, more than 220 poster presentations, three mini symposiums, two panel discussions and the round table. We believe the Congress will provide you with the opportunity to be updated on the advances of the pharmaceutical science and innovative pharmacy practice. It will also provide you with a beneficial exchange of international experiences in order to advance competencies.

Also, we sincerely hope you will enjoy your stay and Octobers days in Belgrade.

We wish you success in your work and pleasant stay.

Prof. dr Ivanka Miletić

Predsednik Organizacionog OdboraPresident of Organizing Committee

Prof. dr Branislava Miljković

Predsednik Naučnog OdboraPresident of Scientific Committee

Page 2: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Naučni odbor Scientific Committee Predsednik / PresidentBranislava Miljković

Članovi / Members

Gordana Vuleta Vesna Matović Vesna Spasojević-Kalimanovska Ljiljana Tasić Slađana Šobajić Radica Stepanović-Petrović Mira Zečević Silvana Petrović Zorica Vujić Jelena Parojčić Stephen Hudson Atilla Hincal Stane Srčič Antonia Trichopoulou Teresa Kowalska

Tehnička podrška Technical support Mirjana Anđić Dragica Stupar

Organizacioni odbor Organizing Committee

Predsednik / PresidentIvanka Miletić

Članovi / Members

Brižita Đorđević Vesela RadonjićDragana JovanovićDubravka UroševIvana Popović Slavica Radović Miroslav Turnić Đurđina JeličićAna Živec SimićZoran SavkovićLusija AvedisijanAleksandar JankovićIvana TrifunovićSrđan Malešev

Izvršni organizatorExecutive Organizer

Smart Travel

Page 3: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Naučno-stručni rad na kongresu odvija se u okviru sledećih sekcija:Scientific work at the Congress is held in the following sections:

Farmaceutska zdravstvena zaštita - apotekarska delatnost (FZZ - APO)Pharmaceutical care -community pharmacy (FZZ - APO)

Farmaceutska zdravstvena zaštita - bolnička farmacija (FZZ-BOL)Pharmaceutical care - hospital pharmacy (FZZ - BOL)

Farmakoinformatika (FI)Pharmacoinformatics (FI)

Farmaceutska tehnologija i kozmetologija (FTK)Pharmaceutical technology and cosmetology (FTK)

Farmakoekonomija (FE)Pharmacoeconomics (FE)

Ispitivanje i kontrola lekova (IKL)Drug analysis and quality control (IKL)

Lekovito bilje (LB)Medicinal plants (LB)

Toksikološka i sanitarna hemija (TSH)Toxicological and sanitary chemistry (TSH)

Medicinska biohemija (MB)Medical biochemistry (MB)

Page 4: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

CENTRALNA DVORANA / CENTRAL HALL

SEKCIJA ZA FARMACEUTSKU ZDRAVSTVENU ZAŠTITU-APOTEKARSKA DELATNOST (FZZ - APO)PHARMACEUTICAL CARE - COMMUNITY PHARMACY SECTION (FZZ - APO)

Drug related problems in elderly patientsProf Ulrich Jaehde, Institute of Pharmacy, Department of Clinical Pharmacy, University of Bonn, Germany

Euro public health needs and the correct educational response from the profession Prof Ian Bates, School of Pharmacy, University of London, Great Britain

Razvoj kompetencija u pružanju farmaceutske zdravstvene zaštite - dali smo spremni?Competency development in pharmaceutical care – are we ready?Arijana Meštrović, Edukacijski centar Atlantic Farmacia, Zagreb, Hrvatska

Koliko su pacijenti informisani o bezbednosnim aspektima preparatakoji se izdaju bez lekarskog recepta?How well are patients informed about safety aspects of over-the-countermedicines?Sandra Vezmar, Jasmina Jevtić Ranđelović, Mirjana Marković, Jelena Gigov,Branislava Miljković

Uloga farmaceuta u pravovremenom otkrivanju osoba koje imajufaktore rizika za osteoporozuThe role of the pharmacist in timely identification of persons withosteoporosis risk factorsTatjana Milošević

Pravilnom upotrebom inhalatora do postizanja optimalnog terapijskogishoda astmeAppropriate use of inhalers for achieving optimal therapeutic outcome of asthmaRoland Antonić, Sandra Vezmar, Milica Pešić, Snežana Lukić

PROGRAM / PROGRAMME

thČetvrtak, 14. oktobar 2010. / Thursday, October 14 , 2010

09:00-11:30

09:00-09:30

09:30-10:00

10:00-10:15

10:15-10:30

10:30-10:45

10:45-11:00

Sreda, 13. oktobar 2010. / Wednesday, October 13th, 2010

18:00-21:00 Svečano otvaranje / Opening ceremony

Plenarno predavanje / Plenary lectureMisija farmacije u javnom zdravlju / Pharmacy's mission in contributing to public health

Prof Stephen Hudson, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Great Britain

Page 5: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

11:00-11:30

12:00-13:00

13:00-13:30

13:30-14:30

13:30-14:30

13:30-14:00

14:00-14:30

14:30-15:00

Diskusija / Discussion

PRVA GALERIJA / THE FIRST GALLERY

Poster prezentacije sekcija FZZ - APO, FI i MBPoster presentations of sections FZZ - APO, FI and MB

Diskusija o odabranim poster prezentacijama sekcija FZZ - APO, FI i MBDiscussion on sections poster presentations FZZ - APO, FI and MB

ANEKS B / ANEX B

Mini simpozijum Agencije za lekove i medicinska sredstva SrbijeMini symposium organized by the Agency for Medicinal Products and Medical DevicesRazvoj farmakovigilance i uspostavljanje sistema vigilance za medicinska sredstva u Republici SrbijiPharmacovigilance development and establishment of vigilance for medical devices in the Republic of SerbiaPredavači/Lecturers: Tatjana Šipetić, Marija Petronijević, Jelena Pilić, Marko Erić, Aleksandra Vujačić Simić

ANEKS A / ANEX A

Panel diskusija: Upravljanje farmaceutskim otpadomPanel discussion: Managing pharmaceutical wasteModeratori/moderators: Ljiljana Tasić, Vukica Kocić Pešić, JelenaManojlović, Tanja Arsić

CENTRALNA DVORANA / CENTRAL HALL

Satelitski simpozijum/Satelitte symposiumAlkaloidSuplementacija vitaminom C - Da li je uvek više bolje?Vitamin C supplementation – Is more always better?Predavač/Lecturer: Prof. dr Branimir Nestorović

Satelitski simpozijum/Satelitte symposium Berlin ChemieFitoterapija benigne hiperplazije prostate (BPH)Phytotherapy of benign prostatic hyperplasia (BPH) Predavač/Lecturer: Dr sc. Zoran Maksimović, Farmaceutski fakultet u Beogradu

Satelitski simpozijum/Satelitte symposium Berlin ChemieNove mogućnosti za terapiju akutnog bolaNew properties for treatment of accute pain Predavač/Lecturer: Prof. dr Slobodan Apostolski, Medicinski fakultet Beograd

Page 6: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

15:00 -15:30

15:30-18:00

15:30-16:00

16:00-16:30

16:30-17:00

17:00-17:30

17:30-18:00

18:00-18:30

Satelitski simpozijum/Satelitte symposiumRichter GedeonTolperison-hidrohlorid: izazov u farmakoterapiji mišićnog spazmaTolperison-hydrochloride: challenge in the pharmacotherapy of muscle spasms Predavač/Lecturer: Ass Marija Milinković, Farmaceutski fakultet u Beogradu

CENTRALNA DVORANA / CENTRAL HALL

SEKCIJA ZA FARMAKOINFORMATIKU (FI)PHARMACOINFORMATICS SECTION (FI)

Uloga endotela u vaskularnim efektima eritropoetina Role of endothelium in vascular effect of erythropoietin Prof. dr Zvonimir Katušić, Mayo Clinic, Minnesota, SAD

Polimikrobne infekcijePolymicrobial infectionsProf. dr Milorad Pavlović, Klinika za infektivne bolesti KCS Beograd,Medicinski fakultet, Univerzitet u Beogradu Spirala stresa u somatskim i mentalnim poremećajimaThe spiral of stress in physical and mental disordersProf. dr Dušica Lečić-Toševski, Jelena Stepanović, Olivera Vuković,Medicinski fakultet, Univerzitet u Beogradu

Savremeni aspekti u lečenju atrijalne fibrilacijeContemporary treatment of atrial fibrillation Dr sci Tatjana Potpara, Klinika za kardiologiju, Klinički centar Srbije

Diskusija / Discussion

CENTRALNA DVORANA / CENTRAL HALL

Satelitski simpozijum/Satelitte symposium MSDNOVI PROIZVODI NOVOG MSD-a NEW PRODUCTS OF THE NEW MSD

Nuvaring - korak dalje za savremenu ženuNuvaring – a step forward for the modern woman Dr Zoran Stanković, Institut za zdravstvenu zastitu majke i deteta"Dr Vukan Čupić"

Page 7: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

15:00-18:00

15:30-16:00

16:00-16:30

16:30-16:45

16:45-17:00

17:00-17:15

17:15-17:30

17:30-18:00

Arcoxia - Preuzmite kontrolu bolaArcoxia – Take over the pain management Dr Predrag Ostojić, Institut za reumatologiju, Beograd

AMFITEATAR / AMPHITHEATER

SEKCIJA ZA MEDICINSKU BIOHEMIJU (MB)MEDICAL BIOCHEMISTRY SECTION (MB)

Oksidativni stres i aterosklerozaOxidative stress and atherosclerosis Doc dr Jelena Kotur-Stevuljevic, Katedra za Medicinsku biohemiju, Farmaceutski fakultet, Univerzitet u Beogradu, Srbija

Procena dijagnostickih procedura i novih biomarkera: koncept imetode analize odnosa troskova i efektivnostiAssessment of diagostic procedures and new biomarkers: the conceptand methods of cost-effectiveness analysisNatasa Bogavac-Stanojevic, Zorana Jelic-Ivanovic, Slavica Spasic, Jelena Kotur-Stevuljevic, Violeta Dopsaj, Dragana Lakic, Katedra za Medicinskubiohemiju, Farmaceutski fakultet, Univerzitet u Beogradu, Srbija

Veza izmedu koncentracije N-terminalnog fragmenta B-tipanatriuretskog peptida i dijastolne disfunkcije leve komore kodpacijenata sa renalnim transplantom Association of N-terminal pro B-type natriuretic peptide with leftventricular diastolic dysfunction in patients with renal transplantLidija Memon, Natasa Bogavac-Stanojevic, Vesna SpasojevicKalimanovska, Sanja Simic-Ogrizovic, Violeta Dopsaj, Jelena Kotur- Stevuljevic

Uticaj pola i starosti na koncentracije holesterola i apolipoproteina Bu malim gustim LDL cesticamaEffect of gender and age on cholesterol and apolipoprotein Bconcentrations in small, dense LDL particlesJelena Vekic, Aleksandra Zeljkovic, Zorana Jelic-Ivanovic, VesnaSpasojevic-Kalimanovska, Lidija Memon, Slavica Spasic

Prirodna autoantitela su znacajan pokazatelj neprogresivne HIVinfekcijeThe natural autoantibodies are a significant marker in non-progressiveHIV infectionAna Đorđević-Vujičić, Milena Veljković, Ursula Dietrich, Maria SakarellosDaitsiotis, Sanja Glišić, Nevena Veljković

Uticaj dve metode za izolaciju RNK na nivo genske ekspresije enzimaSOD-1 i SOD-2 u humanoj krviEffects of two RNA isolation methods on SOD-1 and SOD-2 gene expressionlevels in human bloodAna Vujovic, Vesna Spasojevic-Kalimanovska, Natasa BogavacStanojevic, Slavica Spasic, Jelena Kotur-Stevuljevic

Diskusija / Discussion

Page 8: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

thPetak, 15. oktobar 2010. / Friday, October 15 , 2010

09:00-11:30

09:00-09:30

09:30-09:50

09:50-10:10

10:10-10:25

10:25-10:40

10:40-10:55

10:55-11:30

12:00-13:30

AMFITEATAR / AMPHITHEATER

SEKCIJA ZA FARMAKOEKONOMIJU (FE)PHARMACOECONOMICS SECTION (FE)

Challenges and Opportunities for Pharmacy: Current PracticeCognitive Services and EconomicsProf Martin Schulz, RPh, PhD, FFIP, ABDA, Department of Medicine,Berlin, and Goethe University Frankfurt, Germany

Nacionalna infrastruktura kvaliteta - osnov za pristup EU i slobodnoj trgovini lekovimaNational quality infrastructure - basis for access to the EU and freetrade of medicines Gordana Pejović, Jovan Filipović i Ljiljana Tasić

KIDSCREEN-52 upitnik za procenu kvaliteta života kod dece iadolescenata: Prvi psihometrijski rezultati za srpsku verziju The KIDSCREEN-52 Quality of Life Measure for Children andAdolescents: The first Psychometric Results from Serbian version Tanja Novaković, Dejan Stevanović, Aneta Lakić, Darija KisićTepavčević

Odnos propisivanja anksiolitika i antidepresiva u Srbiji The anxiolytic/antidepressant prescribing ratio in Serbia Nevena Divac, Zoran Todorović, Radan Stojanović, Zorica Nešić,Branislava Medić, Milica Prostran

Farmakoekonomski modeli u farmaciji sa primjerima nesteroidnihantireumatika Pharmacoeconomics models in pharmacy with examples of nonsteroid antirheumatics Armin Škrbo, Vera Dabanović

Promene cena lekova sa liste lekova koji idu na teret Fonda zazdravstveno osiguranje Makedonije nakon uvođenja referentnihcena za nabavku lekova Changes in the prices of medicines from the medicines list reimbursed bythe Health insurance fund in Republic of Macedonia after theimplementation of reference pricing for medicine procurementBistra Angelovska, Verica Ivanovska

Diskusija / Discussion

Skupština farmaceutskog društva SrbijeAssembly of Pharmaceutical Society of Serbia

Page 9: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

09:00-11:30

09:00-09:30

09:30-10:00

10:00-10:30

10:30-11:00

11:00-11:30

11:30-12:00

12:00-13:00

13:00-13:30

13:30-14:30

CENTRALNA DVORANA / CENTRAL HALL

SEKCIJA ZA ISPITIVANJE I KONTROLU LEKOVA (IKL)DRUG ANALYSIS AND QUALITY CONTROL (IKL)

In vitro chiral instability of selected carboxylic acids: experimentalevidence and possible pathwaysTeresa Kowalska, Institute of Chemistry, University of Silesia, Katowice, Poland

LC-MS/MS: a powerful means in bioanalysisYannis Dotsikas, PhD, School of Pharmacy, University of Athens, Athens, Greece

Recent studies of drug molecules by x-ray crystallography and RamanspectroscopyBabur Z. Chowdhry, School of Science, University of Greenwich, Great Britain

Amorphous materials: pharmaceutical importance, detection ancharacterisationMilan D. Antonijević, School of Science, University of Greenwich, GreatBritain

Studije forsirane degradacije različitih generičkih lekovaStudy of forced degradation of several generic drugsMarija Pavlović, Agencija za lekove i medicinska sredstva Srbije, Beograd, Srbija

Diskusija / Discussion

PRVA GALERIJA / THE FIRST GALLERY

Poster prezentacije sekcija FE, IKL i FZZ - BOL Poster presentations of sections FE, IKL and FZZ - BOL

Diskusija o odabranim poster prezentacijama sekcija FE, IKL i FZZ - BOL Discussion on poster presentations of sections FE, IKL, FZZ - BOL

ANEKS A / ANEX A

Panel diskusija / Panel Discussion Usaglašavanje nacionalne regulative sa regulativom Evropske Unije u oblasti lekova i medicinskih sredstavaHarmonization of national legislation with EU legislation in the field of medicines and medical devicesMrs Tijana Radojčić, Ministarstvo zdravlja Republike Srbije, Odsek za lekove i medicinska sredstva

Page 10: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

13:30-14:30

14:30-15:00

15:00-15:30

15:30-18:00

15:30-16:00

16:00-16:30

16:30-16:45

ANEKS B / ANEX B

Panel diskusija / Panel discussionAkutna trovanja lekovima Drug PoisoningUvodna rec / Introduction: Vesna Matovic, Snezana Dordevic,Andelka Spasic

CENTRALNA DVORANA / CENTRAL HALL

Mini simpozijum Farmaceutske Komore Srbije Mini symposium organized by the Pharmaceutical Chamber of Serbia

Kontinuirana edukacija - analiza jednogodisnjeg iskustvaContinuing education - analysis of one year experience(Ucesnici / participants: Dragana Jovanovic, Jela Milic, Gordana Simic,Mirjana Antunovic, Dragana Sovtic, Predrag Petrovic)

CENTRALNA DVORANA / CENTRAL HALL

Satelitski simpozijum/Satellite SymposiumGalenika

Inoviranje proizvodnog programa – profesionalni izazov i odgovornost farmaceutske industrijeInnovation of the production programme – a professional challenge and responsibility of the pharmaceutical industryPrim.dr sc.ph. Suzana Miljkovic, Galenika a.d. - Beograd

CENTRALNA DVORANA / CENTRAL HALL

SEKCIJA ZA FARMACEUTSKU ZDRAVSTVENU ZASTITU - BOLNICKAFARMACIJA (FZZ-BOL)PHARMACEUTICAL CARE - HOSPITAL PHARMACY SECTION (FZZ - BOL)

Professional goals in applying pharmaceutical science to clinical practiceProf Stephen Hudson, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Velika Britanija

Klinicki farmaceuti: uloga i odgovornost (SHPA asocijacija bolnickihfarmaceuta Australije)Clinical pharmacists: role and responsibilities (as per SHPA society ofhospital pharmacists of Australia) Jasminka Nikolajevic-Sarunac, Senior Pharmacist, PharmacyDepartment, John Hunter Hospital, New Lambton Heights, Australia

Aktivnosti udruzenja bolnickih farmaceuta na nivou Evropske unije Activities of hospital pharmacists association in European UnionTajda Miharija Gala, University Medical Centre Ljubljana, Slovenia

Page 11: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

16:45-17:00

17:00-17:15

17:15-17:30

17:30-18:00

18.00-19.00

15:30-18:00

15:30-16:00

16:00-16:20

16:20-16:40

Značaj podataka dobijenih tokom terapijskog monitoringakarbamazepina i valproinske kiseline u optimizaciji terapijeepilepsije uz primenu populacione farmakokinetičke analizeThe importance of therapeutic drug monitoring data in optimization ofepilepsy therapy with carbamazepine and valproic acid using populationpharmacokinetic approachKatarina Vučićević, Branislava Miljković, Milena Pokrajac, Iztok Grabnar,Milica Prostran, Ružica Veličković, Žarko Martinović

Propisivanje humanih albumina u ginekološko-акušerskoj klinici„Narodni Front“ u periodu od 2004-2009 godineThe use of human albumins in the Clinic of gynecology and obstetrics“Narodni Front” in the period 2004-2009Svetlana Ristić, Lenka Kostovska-Mićević, Lazar Pajević, Maja Vasić,Dušan Stanojević

Uloga bolničkog farmaceuta u racionalnoj terapiji antibioticimaRole of hospital pharmacist in rational therapy with antibioticsMilan Tomić, Dragana Rajinac, Marija Kara- Jovanović, Gordana Jevtić, Marina Klančnik, Ljubica Stojičević

Diskusija / Discussion

CENTRALNA DVORANA / CENTRAL HALL

Satelitski simpozijum / Satelitte SymposiaSanofi Aventis d.o.o.

Klinička farmacija-od izazova do mogućnosti/Clinical Pharmacy from challenges to opportunitiesModerator: Prof. Branislava Miljković, Farmaceutski fakultet BeogradPredavači-praktičari: Mr.ph.Jelena Milovanović-Delić, LondonMr.ph. Maxime Japkowicz, Pariz

AMFITEATAR / AMPHITHEATER

SEKCIJA ZA FARMACEUTSKU TEHNOLOGIJU I KOZMETOLOGIJU (FTK) PHARMACEUTICAL TECHNOLOGY AND COSMETOLOGY SECTION (FTK)

Betulsions - an innovative formulation concept for emulsifier free w/oemulsionsRolf Daniels and Marta K. Grysko, Department of PharmaceuticalTechnology, Eberhard Karls University Tübingen, Germany

Primena optimizacionih tehnika zasnovanih na veštačkoj inteligencijiu razvoju farmaceutskih proizvoda Artificial intelligence in pharmaceutical product formulation Svetlana Ibrić, Farmaceutski fakultet, Univerzitet u Beogradu

Uvećanje veličine šarži interaktivnih smeša praškovaPharmaceutical process scale-up for interactive powder mixtures Ljiljana Harding

Page 12: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

16:40-16:55

16:55-17:10

17:10-17:25

17:25-17:40

17:40-17:50

17:50-18:00

Study of the uniformity of the coating thickness of pellets coated by Wurster and swirl flow generator equipped coater Matevž Luštrik, Rok Dreu, Stane Srčič

Primena in silico metoda u razvoju formulacija čvrstih farmaceutskih oblikaApplication of in silico methods in formulation development of solid pharmaceutical dosage forms Jelena Petrović, Svetlana Ibrić, Gabriele Betz, Zorica Đurić

Značaj proučavanja osobina pojedinačnih polimernih molekula zarazumevanje svojstava ksantan matriks tableta Importance of xanthan single molecular properties for understandingbehavior of the matrix tabletsBiljana Govedarica, Saša Baumgartner, Stane Srčič

Predviđanje sadržaja aktivne supstance u intaktnim tabletamaupotrebom NIR spektroskopije i multivarijantne analize podatakaPrediction of drug content in intact tablets using NIR spectroscopy andmultivariate data analysis methods Branko Vranić, Gabriele Betz

Uticaj kontaktne ambalaže na in-use stabilnost hloramfenikol kapi za očiThe effects of packaging on the in-use stability of Chloramphenicol eye dropsNataša Đorđević Filijović, Sanja Kovačević Radonić, Borislava Gavrilov, Nada Marinković

Diskusija / Discussion

Page 13: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

thSubota, 16. oktobar 2010. / Saturday, October 16 , 2010

09:00-11:30

09:00-09:30

09:30-10:00

10:00-10:15

10:15-10:30

10:30-10:45

10:45-11:00

AMFITEATAR / AMPHITHEATER

SEKCIJA ZA LEKOVITO BILJE (LB)MEDICINAL PLANTS SECTION (LB)

Cimicifuga racemosa: od fitohemije do klinikeBlack cohosh (Cimicifuga racemosa): from phytochemistry to the clinicDr Dejan Nikolić, Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, University of Illinois at Chicago, SAD

Bioaktivni sastojci nekih samoniklih biljaka Srbije i Crne GoreBioactive constituents of some wild-growing plants from Serbia and MontenegroProf. dr Slobodan Milosavljević, Hemijski fakultet Univerziteta u Beogradu i Centar za hemiju (IHTM), Beograd

Antioksidantna aktivnost metanolnih ekstrakata Thymus pannonicusAll. (Lamiaceae) sa nekoliko lokaliteta u SrbijiAntioxidant activity of methanol extracts of Thymus pannonicus All.(Lamiaceae) from several localities in SerbiaJelena Arsenijević, Jelena Živković, Ivan Šoštarić, Zoran Maksimović

Hemijski sastav, antimikrobna, antiradikalska i spazmolitičkaaktivnost etarskih ulja Ferula heuffelii Griseb. ex Heuffel (Apiaceae)Chemical composition, antimicrobial, antiradical and spasmolyticactivity of Ferula heuffelii Griseb. ex Heuffel (Apiaceae) essential oilsIvan Pavlović, Silvana Petrović, Marina Milenković, Mirjana Radenković,Suzana Branković, Maria Couladis, Milica Pavlović-Drobac

Medicinski potencijal ekstrakta Allium rotundum subsp. waldsteinii,AlliaceaeHealth properties of extract of wild garlic (Allium rotundum subsp.waldsteinii, Alliaceae)Biljana Božin, Neda Lakić, Isidora Samojlik, Neda Mimica-Dukić, RužicaIgić

Plantago coronopus L. kao potencijalni izvor prirodnihantioksidantnih i antiinflamatornih agenasaPlantago coronopus L. as a potential natural antioxidant and antiinflammatory agentIvana Beara, Marija Lesjak, Dejan Orčić, Nataša Simin, Goran Anačkov,Neda Mimica-Dukić

Page 14: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

11:00-11:15

11:15-11:30

9:00-11:30

09:00-09:30

09:30-10:00

10:00-10:30

10:30-11:00

11:00-11:30

12:00-13:00

13:00-13:30

13:30-15:00

Uloga farmaceuta u savetovanju pacijenata sa benignomhiperplazijom prostateThe role of pharmacists in advising the patients with benign prostatichyperplasiaMira Stojanović, Zoran Maksimović

Diskusija / Discussion

CENTRALNA DVORANA / CENTRAL HALL

SEKCIJA ZA FARMAKOINFORMATIKU (FI)PHARMACOINFORMATICS SECTION(FI)

Lekovi koji utiču na sistem renin-angiotenzin-aldosteronDrugs affecting the renin-angiotensin-aldosterone systemProf. dr Nenad Ugrešić, Katedra za farmakologiju, Farmaceutskifakultet, Univerzitet u Beogradu

Rezistencija na klopidogrel Clopidogrel resistanceProf. dr Radica Stepanović-Petrović, Katedra za farmakologiju,Farmaceutski fakultet, Univerzitet u Beogradu

Statini: vreme za nove indikacije ili za nove neželjene efekte?The statins: time for new indications or for new adverse effects?Doc. dr Miroslav Savić, Katedra za farmakologiju, Farmaceutskifakultet, Univerzitet u Beogradu

Ivabradin – novi lek u terapiji stabilne angine Ivabradine – novel drug in treatment of stable anginaDoc. dr Maja Tomić, Katedra za farmakologiju, Farmaceutski fakultet, Univerzitet u Beogradu

Diskusija / Discussion

PRVA GALERIJA / THE FIRST GALLERY

Poster prezentacije sekcija LB, FTK i TSH Poster presentations of sections LB, FTK and TSH

Diskusija o odabranim poster prezentacijama sekcija LB, FTK i TSH Discussion on poster presentations of sections LB, FTK and TSH

CENTRALNA DVORANA / CENTRAL HALL

Okrugli sto: Aktuelnosti iz farmaceutske struke (predstavnici Farmaceutskog fakulteta, Ministarstva zdravlja, Farmaceutskog društva Srbije, Farmaceutske komore Srbije...

Round table: News from the pharmaceutical profession (representa-tives of the Faculty of Pharmacy, Ministry of Health, Pharmaceutical Society of Serbia, Pharmaceutical Chamber of Serbia...)

Page 15: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

15:30-18:00

15:30-16:00

16:00-16:20

16:20-16:40

16:40-16:55

16:55-17:10

17:10-17:25

17:25-17:40

17:40-18:00

CENTRALNA DVORANA / CENTRAL HALL

SEKCIJA ZA FARMACEUTSKU TEHNOLOGIJU I KOZMETOLOGIJU (FTK)PHARMACEUTICAL TECHNOLOGY AND COSMETOLOGY SECTION (FTK)

Novel applications of surfactants in pharmacyChristel C. Müller-Goymann, Institut für PharmazeutischeTechnologie, Technische Universität Braunschweig, Germany

Preparation, characterisation and application of smart polymeric particlesMartin J. Snowden and Joanna B. Thorne, School of Science, University of Greenwich, United Kingdom

Biološka raspoloživost i bezbednost primene dermatoloških lekova idermokozmetičkih proizvoda: metode za in vitro i in vivo procenuBioavailability and safety of dermatological drugs and dermocosmeticproducts: methods of in vitro/in vivo evaluationSnežana Savić, Farmaceutski fakultet, Univerzitet u Beogradu

Ne-emulgujući i samo-(mikro)emulgujući lipidni nosači lekovitih supstanciNon-emulsifying and self-(micro)emulsifying drug delivery systems Ljiljana Đekić, Marija Primorac

Uticaj vrste biodegradabilnog polimera na submikronske čestice saketoprofenom – ispitivanje fizičkih karakteristika i efikasnostiinkapsulacije lijekaInfluence of biodegradable polymer type on ketoprofen loaded submicron particles - study of physical characterization and drugencapsulation efficiency Sonja Vučen, Gordana Vuleta, Nenad Ignjatović, Dragan Uskoković

Efikasnost kozmetičkih proizvoda – koje efekte je moguće ispitati i kako?Efficacy evaluation of cosmetic products - which effects can be measured and how? Milica Lukić, Ivana Jakšić, Gordana Vuleta

Status i bezbednost nanokozmetičkih proizvoda Nanocosmetics - legal status and health risksGordana Vuleta, Radava Korać, Snežana Savić

Diskusija / Discussion

Page 16: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

15:30-18:00

15:30-16:00

16:00-16:30

16:30-17:00

17:00-17:30

17:30-18:00

18:00-18:30

AMFITEATAR / AMPHITHEATER

SEKCIJA ZA TOKSIKOLOŠKU HEMIJU I SEKCIJA ZA SANITARNU HEMIJU(TSH)TOXICOLOGICAL AND SANITARY CHEMISTRY SECTION (TSH)

Xenobiotic/Drug metabolizing enzyme polymorphisms: their role inresponse to chemotherapy and survival in lung cancerProf Mumtaz Iscan, Department of Toxicology, Faculty of Pharmacy,Ankara University, Turska

Mediterranean diet and health Prof Antonia Trichopoulou, Department of Hygiene and Epidemiology, School of Medicine, University of Athens, Grčka

Budućnost nanomedicine? Future of nanomedicine?Prof. Mirjana Đukić, Katedra za toksikologiju „Akademik DaniloSoldatović“ Farmaceutskog fakulteta Univerziteta u Beogradu

Dijetetski proizvodi i dodaci ishrani - nova regulativa Food for particular nutritional uses and food supplements – new regulation Prof. Ivan Stanković, Katedra za bromatologiju Farmaceutskog fakulteta Univerziteta u Beogradu, Srbija

Diskusija / Discussion

AMFITEATAR / AMPHITHEATER

Zatvaranje Kongresa / Closing word

Biće organizovani izleti zavisno od zainteresovanosti učesnika:Sremski Karlovci, Resava-Manasija, Topola-Aranđelovac, Smederevska tvrđava.Svi autobusi polaze sa parkinga Sava centra (savska strana)Prijava za izlete i preuzimanje vouchera, najkasnije do 14. oktobra u 14:00h na Registracionom pultu.Informacije: Turistička agencija SMART.

Congress tours will be organized depending on the participants interest:Sremski Karlovci, Resava-Manasija, Topola-Aranđelovac, Smederevo Fortress.Departure of buses: parking area in front of Sava Center (riverside).Registration for excursions and issue of vouchers: Registration Desk, 14th October at 14.00 the latest.Information: Travel Agency SMART.

thNedelja, 17. oktobar 2010. / Sunday, October 17 , 2010

Page 17: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Poster prezentacije sekcija FZZ – APO, FI i MBPoster presentations of sections FZZ – APO, FI and MB

Prisustvo autora Presence of authors

Diskusija o odabranim poster prezentacijama sekcija FZZ – APO, FI i MBDiscussion on poster presentations of sections FZZ – APO, FI and MB

thČetvrtak, 14. oktobar 2010. / Thursday, October 14 , 2010

09:00-18:00

12:00-13:00

13:00-13:30

POSTER SEKCIJA / POSTER SECTION

SEKCIJA ZA FARMACEUTSKU ZDRAVSTVENU ZAŠTITU – APOTEKARSKA DELATNOST (FZZ – APO) PHARMACEUTICAL CARE – COMMUNITY PHARMACY SECTION (FZZ – APO)

FZZ-APO-1 TELEPHONE INTERVENTION BY COMMUNITY PHARMACY IMPROVES MEDICATION COMPLIANCE Dragoslav Dupalo, PharmD, Beatrixapotheek Den Helder, The Netherlands

FZZ-APO-2 INFORMISANOST RODITELJA O BOLESTI DISAJNIH PUTEVA U DECE PARENTS AWARENESS ABOUT RESPIRATORY DIESEASES IN CHILDREN Gordana Tanasijević, Marija Pešić

FZZ-APO-3 PROCENA PRAVILNE PRIMENE TERAPIJE OD STRANE PACIJENATA U TRETMANU HRONIČNOG KANCERSKOG BOLA EVALUATION OF APPROPRIATE ADMINISTRATION OF CHRONIC CANCER PAIN THERAPY BY PATIENTS Ivana Baričić, Eva Koči

FZZ-APO-4 UPUTSTVO ZA LEK U SLUŽBI PACIJENTA PATIENT INFORMATION LEAFLET IN THE SERVICE OF THE PATIENT Katarina Tešić-Stijepović,Olga Bogojević,Dragana Radovanović

FZZ-APO-5 REZULTATI ANKETE O POZNAVANJU NEŽELJENIH REAKCIJA NA LEKOVE OD STRANE PACIJENATA RESULTS OF THE SURVEY ON THE KNOWLEDGE OF ADVERSE DRUG REACTIONS BY PATIENTS Mika Simišić, Danijela Dobrosavljević, Sandra Vranić

FZZ-APO-6 UPOTREBA, INTERAKCIJE I NEŽELJENA DEJSTVA INHIBITORA PREUZIMANJA SEROTONINA THE USE, INTERACTIONS AND ADVERSE EFFECTS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS Milan Čarapić

Page 18: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

FZZ-APO-7 LEKOVI KOJI SE NAJVIŠE IZDAJU NA LEKARSKI RECEPT U APOTEKARSKOJ JEDINICI PAPAZOVAC U SMEDEREVU DRUGS THAT ARE MOST ISSUED ON PRESCRIPTION IN THE PARMACEUTICAL UNIT PAPAZOVAC IN SMEDEREVO Milena Slavković

FZZ-APO-8 INFORMISANOST PACIJENATA O URGENTNOJ KONTRACEPCIJI HOW WELL ARE OUR PATIENTS INFORMED ABOUT EMERGENCY CONTRACEPTION? Milica Pešić, Gordana Stanisavljević, Jasmina Arsić, Roland Antonić, Kristina Dimić, Sandra Vezmar

FZZ-APO-9 ADHERENCIJA TERAPIJI OSTEOPOROZE ADHERENCE TO OSTEOPOROSIS THERAPY Nataša Radosavljević, Zoran Radosavljević, Predrag Vukomanović

FZZ-APO-10 NOVA ULOGA TALIDOMIDA-PRAĆENJE PROPISIVANJA NEW ROLE OF THALIDOMIDE-FOLLOWING PRESCRIPTIONS Nataša Stefanović

FZZ-APO-11 EDUKATIVNA ULOGA FARMACEUTA U SPREČAVANJU NEŽELJENIH DEJSTAVA NESTERODINIH ANTIINIFLAMATORNIH LEKOVA EDUCATIONAL ROLE OF PHARMACIST IN PREVENTING ADVERSE EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS Predrag Vukomanović, Nataša Radosavljević, Zoran Radosavljević

FZZ-APO-12 UTICAJ PREPORUKE APOTEKARA NA ODLUKU PACIJENTA O IZBORU LEKOVA KOJI SE IZDAJU BEZ LEKARSKOG RECEPTA IMPACT OF PHARMACIST'S RECOMMENDATION ON PATIENT'S PURCHASE DECISION, IN OVER-THE-COUNTER PHARMACY MARKET IN SERBIA Sanja Ivanović

FZZ-APO-13 PRIKAZ REZULTATA INTERVJUA PACIJENATA LEČENIH OD OSTEOPOROZE SPROVEDENIH U APOTECI “DR. SIMA MILOŠEVIĆ” U BEOGRADU THE REVIEW OF THE RESULTS BASED ON INTERVIEW WITH PATIENTS TREATED FOR OSTEOPOROSIS IN PHARMACY “DR. SIMA MILOŠEVIĆ” IN BELGRADE Slavica Nikolić

FZZ-APO-14 DA LI SU PACIJENTI DOVOLJNO INFORMISANI O PRIMENI LEKOVA KOJI SE IZDAJU BEZ LEKARSKOG RECEPTA? ARE PATIENTS WELL ENOUGH INFORMED ABOUT OVER-THE-COUNTER MEDICINES? Snežana Živanović, Sandra Vezmar

FZZ-APO-15 UPOTREBA FOLNE KISELINE TOKOM PRVOG TRIMESTRA TRUDNOĆE U SRBIJI USE OF FOLIC ACID DURING THE FIRST TRIMESTER OF PREGNANCY IN SERBIA Sonja Stojiljković

FZZ-APO-16 FARMACEUT U APOTECI-ZABORAVLJENI ČLAN U TIMU ZDRAVSTVENE ZAŠTITE? PHARMACIST-THE FORGOTTEN MEMBER OF HEALTH CARE TEAM? Vesna Đorđević

Page 19: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

FZZ-APO-17 KOMPLIJANSA KOD PACIJENATA SA BENIGNOM HIPERPLAZIJOM PROSTATE

COMPLIANCE IN PATIENTES WITH BENIGN PROSTATIC HYPERPLASIA

Zoran Radosavljević, Nataša Radosavljević, Predrag Vukomanović

FZZ-APO-18 PRIMENA INFORMACIONIH TEHNOLOGIJA U PROMOCIJI ZDRAVLJA U APOTECI

SUBOTICA

APPLICATION OF INFORMATION TECHNOLOGY IN HEALTH PROMOTION IN

PHARMACY SUBOTICA

Aleksandar Malagurski, Jelena Blažin, Sandra Ćupić

FZZ-APO-19 SAŽETAK KARAKTERISTIKA LEKA (SMPC) - INFORMACIJE NAMENJENE ZDRAVSTVENIM

RADNICIMA

SUMMARY OF PRODUCT CHARACTERISTICS (SMPC) –INFORMATION

FOR HEALTH PROFESSIONALS

Jasmina Bašić, Katarina Kovačević, Danka Tešić, Tanja Neđić, Vladan Savić

FZZ-APO-20 ANALIZA AKTIVNOSTI APOTEKE SUBOTICA U PROMOCIJI JAVNOG ZDRAVLJA

ANALYSIS OF PUBLIC HEALTH PROMOTION ACTIVITIES CONDUCTED BY

PHARMACY SUBOTICA

Tatjana Crnjanski, Svetlana Rudinski-Stojkov, Ljiljana Tasić, Ivana Tadić,

Dušanka Krajnović, Andrijana Milošević

FZZ-APO-21 UTICAJ PONAŠANJA FARMACEUTA NA ADHERENCU

INFLUENCE OF PHARMACIST BIHAVIOR ON ADHERENCE

Dragana Jocić, Dušanka Krajnović

FZZ-APO-22 PRUŽANJE SPECIFIČNE FARMACEUTSKE USLUGE NA PRIMERU APOTEKE VRŠAC

PROVIDING SPECIFIC PHARMACY SERVICE – CASE STUDY PHARMACY VRŠAC

Stana Tirnanić, Ivana Tadić

FZZ-APO-23 STAVOVI FARMACEUTA O KOMPLIJANSI U REGIONIMA SRBIJE

THE PHARMACISTS' ATTITUDES ON COMPLIANCE IN THE REGIONS OF SERBIA

Ivana Tadić, Svetlana Stojkov-Rudinski, Tatjana Crnjanski, Ljiljana Tasić

FZZ-APO-24 ASPEKTI ŽIVOTNE SREDINE I UPRAVLJANJE FARMACEUTSKIM OTPADOM U

APOTECI BEOGRAD

ENVIRONMENTAL ASPECTS AND MANAGEMENT OF PHARMACEUTICAL WASTE IN

BELGRADE

Milanković Rade, Jović Sanja

FZZ-APO-25 ULOGA APOTEKE U ZBRINJAVANJU STARIH LEKOVA IZ DOMAĆINSTAVA

THE ROLE OF PHARMACY IN MANGEMENT OF OLD DRUGS IN HOUSEHOLDS

Jelena Manojlović, Sunčica Todorović, Filip Todorović

Page 20: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

FZZ-APO-26 UPRAVLJANJE FARMACEUTSKIM OTPADOM – STAVOVI KORISNIKA APOTEKE SUBOTICA PHARMACEUTICAL WASTE MANAGEMENT – THE ATTITUDES OF PHARMACY SUBOTICA'S PATIENTS Svetlana Stojkov-Rudinski, Ivana Tadić, Jasmina Vukša, Bojana Zrnić, Ljiljana Tasić, Dušanka Krajnović

SEKCIJA ZA FARMAKOINFORMATIKU (FI) PHARMACOINFORMATICS SECTION (FI)

FI–1 LOKALNO PERIFERNO ANALGETIČKO DEJSTVO LEVETIRACETAMA JE POSREDOVANO ALFA -ADRENERGIČKIM RECEPTORIMA 2

THE INVOLVEMENT OF ALPHA -ADRENOCEPTORS IN THE LOCAL PERIPHERAL 2

ANALGESIC EFFECT OF LEVETIRACETAM Ana Micov, Maja Tomić, Radica Stepanović-Petrović

FI–2 ULOGA GABA RECEPTORA KOJI SADRŽE ΑLFA1 PODJEDINICU U RAZVOJU A

MOTORNE INKOORDINACIJE PRI PRIMENI DIAZEPAMA CONTRIBUTION OF ALPHA1 SUBUNIT-CONTAINING GABA RECEPTORS TO A

DIAZEPAM-INDUCED MOTOR IMPAIRMENT Jovana Divljaković, Marija Milinković, Tamara Timić, Srđan Joksimović, Miroslav Savić

FI-3 VAZORELAKSANTNI EFEKAT NIKORANDILA NA IZOLOVANOJ HUMANOJ UNUTRAŠNJOJ MAMILARNOJ ARTERIJI THE VASORELAXANT EFFECTS OF NICORANDIL IN THE ISOLATED HUMAN INTERNAL MAMMARY ARTERY Marija Pavlović, Aleksandra Novaković, Miodrag Perić, Milan Babić, Milan Ćirković, Slavica Ristić, Ljiljana Gojković Bukarica

FI–4 FARMAKOLOŠKO ISPITIVANJE 3-KARBOMETOKSI FENTANILA U MIŠEVA PHARMACOLOGICAL EVALUATION OF 3-CARBOMETHOXY FENTANYL IN MICE Sonja Vučković, Milica Prostran, Katarina Savić Vujović, Zorica Nešić, Milovan Ivanović, Ljiljana Došen-Mićović

FI–5 ANTIARITMIJSKA TERAPIJA KOD BOLESNIKA SA ATRIJALNOM FIBRILACIJOM ANTIARRHYTHMIC DRUG THERAPY IN ATRIAL FIBRILLATION Tatjana Potpara, Marija Polovina, Gordana Potpara-Marković

FI -6 ZNAČAJ UPUTSTVA ZA LEK U INFORMACIONOM DRUŠTVU THE IMPORTANCE OF PATIENT INFORMATION LEAFLET IN THE INFORMATION SOCIETY Danka Tešić, Tanja Neđić, Katarina Kovačević, Jasmina Bašić, Vladan Savić

FI–7 PROCEDURA MEĐUSOBNOG PRIZNAVANJA (MRP) I DECENTRALIZOVANA PROCEDURA (DCP) ZA REGISTRACIJU LEKOVA U EU MUTUAL RECOGNITION PROCEDURE (MRP) AND DECENTRALISED PROCEDURE (DCP) FOR REGISTRATION OF MEDICINAL PRODUCTS IN EU Zorica Pejčić, Tanja Neđić

Page 21: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

FI–8 BOLNIČKA POTROŠNJA CEFALOSPORINA CEHPALOSPORINS HOSPITAL CONSUMPTION Jelena Brusić-Renaud, Mirjana Antunović

FI–9 PROCENA INFORMISANOSTI SRPSKIH VRHUNSKIH SPORTISTA O DOPINGU EVALUATION OF THE INFORMATION LEVEL ON DOPING WITH HIGH LEVEL SERBIAN ATHLETES Dušan Antić, Sergej Ostojić

FI-10 THE ROLE OF THE PHARMACOINFORMATICS IN THE IMPROVEMENT OF THE PHARMACEUTICAL CARE Maja Kovaceva, Jasminka Patceva, Biljana Lazarova, Lidija Petrusevska Tozi, Kristina Mladenovska

FI–11 STATISTIČKI POKAZATELJI O PREVENCIJI, LIJEČENJU I INFORMISANOSTI O RAKU VRATA MATERNICE U BOSNI I HERCEGOVINI STATISTICAL INDICATORS ON PREVENTION, TREATMENT AND AWARENESS OF CERVICAL CANCER IN BOSNIA AND HERZEGOVINA Armin Škrbo, Dženita Bajrambašić, Selma Škrbo

FI-12 NOVOREGISTROVANI LEKOVI U REPUBLICI SRBIJI THE NEWLY REGISTERED DRUGS IN THE REPUBLIC OF SERBIA Tatjana Kolarska, Marija Janković

FI-13 FARMACEUTSKI ZDRAVSTVENI RADNICI U ZDRAVSTVENOM SISTEMU REPUBLIKE SRBIJE THE PHARMACEUTICAL HEALTH PROFESSIONALS IN THE RS HEALTH SYSTEM Tatjana Kolarska, Anđelka Dželetović

FI-14 CENTAR ZA INFORMACIJE O LEKOVIMA- ANALIZA POZIVA KORISNIKA DRUG INFORMATION CENTER - USER CALLS ANALYSIS Nikola Radunović

SEKCIJA ZA MEDICINSKU BIOHEMIJU (MB) MEDICAL BIOCHEMISTRY SECTION (MB)

MB-1 OŠTEĆENJE DNK ISPITIVANO KOMETA ESEJOM PRE I NAKON SUPLEMENTACIJE ASTAKSANTINOM KOD FUDBALERA DNA DAMAGE DETECTED BY THE COMET ASSAY BEFORE AND AFTER ASTAXANTHIN SUPPLEMENTATION IN FOOTBALL PLAYER Miron Sopić, Nataša Bogavac-Stanojević, Ivana Baralić, Brižita Đorđević, Jelena Kotur - Stevuljević, Zorana Jelić – Ivanović

MB-2 PROMENE U AKTIVNOSTI I FENOTIPSKOJ DISTRIBUCIJI ENZIMA PARAOKSONAZE 1 U TOKU NORMALNE TRUDNOĆE CHANGES OF PARAOXONASE ACTIVITY AND PARAOXONASE PHENOTYPE DISTRIBUTION THROUGHOUT NORMAL PREGNANCY Aleksandra Stefanović, Jelena Kotur-Stevuljević, Danijela Ardalić,Vesna Mandić-Marković, Željko Miković, Slavica Spasić

Page 22: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

MB-3 CHARACTERIZATION OF N-LINKED OLIGOSACCHARIDES IN IMMUNOREACTIVE GLYCOPROTEINS FROM PERIPHERAL NERVE AND CAMPYLOBACTER JEJUNI O:19 Ana Poceva-Panovska, Katerina Brezovska, Aleksandra Grozdanova, Ljubica Suturkova, Slobodan Apostolski

MB-4 RASPODELE LDL I HDL SUBFRAKCIJA I KLINIČKI ZNAČAJ NJIHOVOG ODREĐIVANJA U RAZLIČITIM BOLESTIMA POVEZANIM SA RAZVOJEM ATEROSKLEROZE DISTRIBUTIONS OF LDL AND HDL SUBFRACTIONS AND CLINICAL SIGNIFICANCE OF THEIR ASSESSMENT IN VARIOUS ATHEROSCLEROSIS-RELATED DISEASES Aleksandra Zeljković, Jelena Vekić, Vesna Spasojević-Kalimanovska, Zorana Jelić-Ivanović, Nataša Bogavac-Stanojević, Aleksandra Stefanović

MB-5 POVEZANOST BIOHEMIJSKIH I HISTOLOŠKIH PROMENA KOD ISHEMIJSKO- REPERFUZIJSKOG OŠTEĆENJA BUBREGA U EKSPERIMENTALNOM MODELU RELATIONSHIP BETWEEN BIOCHEMICAL AND HISTOPATHOLOGICAL FINDINGS DURING ISCHEMIA / REPERFUSION KIDNEY INJURY IN EXPERIMENTAL RAT MODEL Zorica Nešić, Zoran Todorović, Branislava Medić, Gordana Basta-Jovanović, Nevena Divac, Milica Prostran

MB-6 FARMAKOVIGILANCA I HEMOVIGILANCA KOD LEKOVA DOBIJENIH IZ HUMANE PLAZME PHARMACOVIGILANCE AND HAEMOVIGILANCE IN STABILE PRODUCTS DERIVED FROM HUMAN PLASMA Marija Romić

MB-7 OKSIDATIVNO-STRESNI STATUS PACIJENATA SA SARKOIDOZOM I KORELACIJA SA KLINIČKIM PARAMETRIMA OXIDATIVE STRESS STATUS IN SARCOIDOSIS PATIENTS AND CORRELATION WITH CLINICAL PARAMETERS Jasmina Ivanišević, Jelena Kotur-Stevuljević, Aleksandra Stefanović, Zorana Jelić-Ivanović, Slavica Spasić, Violeta Vučinić-Mihailov

MB-8 PARAMETRI OKSIDATIVNOG STRESA I ANTIOKSIDATIVNE ZAŠTITE KOD PACIJENATA SA SHIZOFRENIJOM PARAMETERS OF OXIDATIVE STRESS AND ANTIOXIDATIVE PROTECTION IN PATIENTS WITH SCHIZOPHRENIA Bojana Vidović, Brižita Đorđević , Jelena Kotur-Stevuljević, Aleksandra Stefanović, Čedo Miljević, Dušica Lečić-Toševski

MB-9 REAKTIVNI PROTEINSKI KARBONILI U PRAĆENJU OKSIDATIVNOG STRESA KOD PACIJENATA NA HEMODIJALIZI REACTIVE PROTEIN CARBONYLS FOR MONITORING OXIDATIVE STRESS IN HEMODIALYSIS PATIENTS Jasmina Pavičić, Jelena Kotur-Stevuljević, Tatjana Ivanić-Ćorlomanović, Aleksandra Stefanović, Ana Vujović, Vesna Spasojević-Kalimanovska

MB-10 TOTALNI OKSIDANTNO – ANTIOKSIDANTNI STATUS KOD PACIJENATA SA KORONARNOM ARTERIJSKOM BOLEŠĆU TOTAL OXIDATIVE – ANTIOXIDANT STATUS IN CORONARY ARTERY DISEASE PATIENTS Aleksandra Vukašinović, Dragica Ristić, Jelena Kotur-Stevuljević, Vesna Spasojević-Kalimanovska, Slavica Spasić, Aleksandra Stefanović

Page 23: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Poster prezentacije sekcija IKL, FZZ – BOLPoster presentations of sections IKL and FZZ – BOL

Prisustvo autora Presence of authors

Diskusija o odabranim poster prezentacijama sekcija IKL, FZZ – BOLDiscussion on poster presentations of sections IKL and FZZ – BOL

thPetak, 15. oktobar 2010. / Friday, October 15 , 2010

09:00-18:00

12:00-13:00

13:00-13:30

SEKCIJA ZA ISPITIVANJE I KONTROLU LEKOVA (IKL) DRUG ANALYSIS AND QUALITY CONTROL SECTION (IKL)

IKL-1 OBELEŽAVANJE PAKOVANJA LEKA: USAGLAŠENOST SA REGULATORNIM ZAHTEVIMA MEDICINAL PRODUCT LABELLING: COMPLIANCE WITH REGULATORY REQUIREMENTS Gordana Žigić, Svjetlana Mihaljica

IKL-2 DERIVATI PLAZME -STABILNI LEKOVI IZ KRVI REGULATORNI ASPEKT PLASMA - DERIVED MEDICINAL PRODUCTS REGULATORY REQUIREMENTS Vesna Popržen, Svjetlana Mihaljica

IKL-3 PRAĆENJE SOLVOLIZE NOVIH ESTARSKIH DERIVATA FLUOCINOLON ACETONIDA I POREĐENJE SA FLUOCINONIDOM PRIMENOM DERIVATIVNE UV SPEKTROFOTOMETRIJE I RP-HPLC – IN VITRO MODEL ZA AKTIVIRANJE PREDLEKA SOLVOLYSIS OF A NOVEL ESTER DERIVATIVES OF FLUOCINOLONE ACETONIDE IN COMPARISON WITH FLUOCINONIDE ASSAYED BY UV DERIVATIVE SPECTROPHOTOMETRY AND RP-HPLC – IN VITRO MODEL SYSTEM FOR PRODRUG ACTIVATION Bojan Marković, Sote Vladimirov, Olivera Čudina,Vladimir Savić, Katarina Karljiković-Rajić

IKL-4 RAZVOJ BIORELATIVNOG TESTA ZA PRAĆENJE BRZINE RASTVARANJA KLOPIDOGRELA IZ TABLETA SA TRENUTNIM OSLOBAĐANJEM NA OSNOVU IN VITRO REZULTATA EVALUATION OF BIORELEVANT IN VITRO TEST FOR CLOPIDOGREL IMMEDIATE RELEASE TABLETS BASED ON IN VIVO RESULTS Aleksandra Spasić, Maja Stojanović, Irena Homšek

IKL-5 OBELEŽAVANJE HEDP ITRIJUMOM-90 ZA TERAPIJU METASTAZA U KOSTIMA LABELLING OF HEDP WITH 90Y FOR THE TREATMENT OF BONE METASTASES Dragana Stanković, Drina Janković, Nadežda Nikolić, Sanja Vranješ-Đurić, Pavle Glodić, Magdalena Lazarević

Page 24: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

IKL-6 ODREĐIVANJE LIZINOPRILA U HUMANOJ PLAZMI METODOM HPLC I PRIMENA U STUDIJI BIOEKVIVALENCIJE QUANTITATIVE DETERMINATION OF LISINOPRIL IN HUMAN PLASMA BY HPLC METHOD AND ITS APPLICATION IN A BIOEQIVALENCE STUDY Rumenka Petkovska, Aneta Dimitrovska, Liljana Ugrinova, Liljana Labacevska- Gjatovska, Nikola Labacevski

IKL-7 VIŠESTRUKA IN VITRO/IN VIVO KORELACIJA NIVOA C: PRIMER TABLETA SA TRENUTNIM OSLOBAĐANJEM LEVOTIROKSIN NATRIJUMA MULTIPLE LEVEL C IN VITRO/IN VIVO CORRELATION OF DISSOLUTION PROFILES: LEVOTHYROXINE SODIUM IMMEDIATE RELEASE TABLETS CASE STUDY Ivana Kocić, Irena Homšek, Mirjana Dačević, Branislava Miljković

IKL-8 ICH Q8, Q9 I Q10-IZAZOVI I MOGUĆNOSTI SA ASPEKTA FARMACEUTSKE INDUSTRIJE GENERIKA ICH Q8, Q9 AND Q10 - CHALLENGES AND OPPORTUNITIES FROM A GENERIC PHARMACEUTICAL INDUSTRY POINT OF VIEW Ljuba Karanakov, Jasmina Tonic-Ribarska, Suzana Trajkovic-Jolevska

IKL-9 ISTOVREMENO ODREĐIVANJE KARBAMAZEPINA I KARBAMAZEPIN-10,11-EPOKSIDA U HUMANOJ PLAZMI HPLC METODOM SIMULTANEOUS DETERMINATION OF CARBAMAZEPINE AND CARBAMAZEPINE-10, 11-EPOXIDE IN HUMAN PLASMA BY HPLC METHOD Jasmina Tonic-Ribarska, Zoran Sterjev, Ljubica Šuturkova, Suzana Trajkovic-Jolevska

IKL-10 ISPITIVANJE DEGRADACIJE API TOKOM PRELIMINARNE STUDIJE STABILNOSTI INVESTIGATION OF API DEGRADATION IN DRUG PRODUCT PRELIMINARY STABILITY STUDY Violeta Dolovac

®IKL-11 PRAĆENJE STABILNOSTI SPALMOTIL ORALNOG RASTVORA U PREDLOŽENOM ROKU TRAJANJA STABILITY TESTING OF SPALMOTIL® ORAL SOLUTION THROUGH THE PROPOSED SHELF-LIFE PERIOD Biljana Stojanović, Jelena Veljković, Stojanka Vidović, Mirjana Rajić, Ljiljana Petrović, Marija Milovanović

IKL-12 PRIMENA VISOKOEFIKASNE TEČNE HROMATOGRAFIJE U ANALIZI PROKAIN BENZILPENICILINA, BENZATIN BENZILPENICILINA, DIHIDROSTREPTOMICIN SULFATA I PROKAIN HIDROHLORIDA U FARMACEUTSKIM RASTVORIMA HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC ANALYSIS OF BENZYLPENICILINE, BENZATHYN BENZYLPENICILLINE, DIHYDROSTREPTOMYCIN SULPHATE, PROCAINE HYDROCHLORIDE IN PHARMACEUTICAL SOLUTION Snežana Đorđević, Vesna Kilibarda, Milica Zlatković, Sonja Ćosić, Ljiljana Lupšić

IKL-13 POSTAVLJANJE SPECIFIKACIJE DEGRADACIONIH PROIZVODA: ASPEKTI I SMERNICE SETTING DEGRADATION PRODUCTS SPECIFICATION: ASPECTS AND GUIDELINES Slobodanka Cvetićanin, Dragana Kostić, Dejan Mijalković, Nataša Đorđević Filijović, Nada Marinković

Page 25: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

IKL-14 ODREĐIVANJE LIZINOPRILA U FARMACEUTSKIM OBLICIMA PRIMENOM KINETIČKE METODE DETERMINATION OF LISINOPRIL IN PHARMACEUTICALS BY A KINETIC METHOD Mira Čakar, Gordana Popović

IKL-15 RAZDVAJANJE I MIGRACIONO PONAŠANJE ANTIHIPERTENZIVA SA CENTRALNIM DEJSTVOM I DIURETIKA METODOM KAPILARNE ELEKTROFOREZE UZ PRIMENU CIKLODEKSTRINA SEPARATION AND MIGRATION BEHAVIOR OF SOME CENTRALLY ACTING ANTIHYPERTENSIVES AND DIURETICS BY CYCLODEXTRIN-MEDIATED CAPILLARY ELECTROPHORESIS Slavica Filipić, Katarina Nikolić, Irena Vovk, Mitja Križman, Danica Agbaba

IKL-16 RP-HPLC METODA ZA ODREĐIVANJE SADRŽAJA BISOPROLOLA I NJEGOVIH SRODNIH SUPSTANCI U BISOPROLOL® 5MG TABLETAMA RP-HPLC METHOD FOR DETERMINATION OF BISOPROLOL AND ITS IMPURITIES IN BISOPROLOL® 5 MG DOSAGE FORM Milkica Crevar Sakač, Vedrana Savić, Janko Ignjatović, Zorica Vujić

IKL-17 QSAR PREDVIĐANJE HEPATIČKOG I UKUPNOG KLIRENSA LEKOVA QSAR PREDICTION OF HEPATIC MICROSOMAL INTRINSIC CLEARANCE AND HUMAN CLEARANCE VALUES FOR DRUGS Katarina Nikolić, Slavica Filipić, Danica Agbaba

IKL-18 UTICAJ MEDIJA NA FLUORESCENCIJU EUROPIJUM (III) OKSITETRACIKLIN KOMPLEKSA MEDIUM EFFECTS ON FLUORESCENCE OF EU (III)-OXYTETRACYCLINE CHELATE Ervina Bečić, Miroslav Šober, Belma Imamović, Elma Makarević, Mirza Dedić, Amra Hrvat

IKL-19 LISTA ZA OBELEŽAVANJE SPOLJNJEG I UNUTRAŠNJEG PAKOVANJA LEKA ZA HUMANU UPOTREBU INFORMATION LIST FOR OUTER AND IMMEDIATE PACKAGING OF MEDICINAL PRODUCT FOR HUMAN USE (LABELLING LIST) Sofija Vrcelj-Jovanović, Ljiljana Vojvodić, Boris Bojić

IKL-20 RAZVOJ I OPTIMIZACIJA RP-HPLC METODE ZA ODREĐIVANJE ZOLPIDEM-TARTARATA I NJEGOVIH DEGRADACIONIH PROIZVODA U TABLETAMA DEVELOPMENT AND OPTIMIZATION OF RP-HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF ZOLPIDEM TARTRATE AND ITS DEGRADATION PRODUCTS IN TABLETS Marija Malešević, Ljiljana Živanović, Žarko Jović

IKL-21 TEST ISPITIVANJE BRZINE OSLOBAĐANJA LEKOVITE SUPSTANCE DISSOLUTION TEST Gordana Petrović, Marija Pavlović

IKL-22 ISPITIVANJA I ZAHTEVI U SPECIFIKACIJI AKTIVNE SUPSTANCE I GOTOVOG PROIZVODA SPECIFICATION TESTS AND ACCEPTANCE CRITERIA FOR ACTIVE SUBSTANCE AND DRUG PRODUCT Mirjana Jovanović, Sofija Vrcelj-Jovanović, LjiljanaVojvodić

Page 26: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

IKL-23 DEGRADACIONI PROIZVODI U LEKU: INTERAKCIJE SA EKSCIPIJENSIMA DEGRADATION PRODUCTS:INTERACTIONS WITH EXCIPIENTS Sofija Vrcelj-Jovanović, Ljiljana Vojvodić, Mirjana Jovanović

IKL-24 PRIMENA BENČMARKING METODOLOGIJE U UNAPREĐENJU REGULATORNE PERFORMANSE AGENCIJE ZA LEKOVE I MEDICINSKA SREDSTVA SRBIJE BENCHMARKING METHODOLOGY AS A TOOL IN MEDICINES AND MEDICAL DEVICES AGENCY OF SERBIA REGULATORY PERFORMANCE IMPROVEMENT Gordana Pejović

IKL-25 UTICAJ PREMAZIVANJA PLOČA KASKADNOG IMPAKTORA NA AERODINAMIČKU DISTRIBUCIJU VELIČINE ČESTICA INFLUENCE OF PLATE COATING ON AERODYNAMIC ASSESSMENT OF FINE PARTICLES Amar Elezović, Amela Saračević, Alija Uzunović, Saša Pilipović, Šeherzada Hadžidedić, Alisa Elezović IKL-26 HEMIJSKI RAZVOJ NOVE AKTIVNE SUPSTANCE: POTENCIJALNE NEČISTOĆE DEVELOPMENT OF NEW ACTIVE SUBSTANCE: POTENTIAL IMPURITIES Ljiljana Vojvodić, Mirjana Jovanović, Sofija Vrcelj-Jovanović

IKL-27 ISPITIVANJE STABILNOSTI I KINETIKA RAZGRADNJE PRAMIPEKSOLA PRIMENOM TEČNE HROMATOGRAFIJE INVESTIGATION OF PRAMIPEXOLE STABILITY AND DEGRADATION KINETICS USING LIQUID CHROMATOGRAPHY Nađa Kostić, Anđelija Malenović, Biljana Jančić-Stojanović

IKL-28 EVALUACIJA METODE TEČNE HROMATOGRAFIJE ZA ANALIZU ROPINIROLA I NJEGOVE NEČISTOĆE NASTALE OKSIDACIJOM EVALUATION OF LIQUID CHROMATOGRAPHIC METHOD FOR ANALYSIS OF ROPINIROL AND ITS IMPURITY ARISING FROM OXIDATION Tijana Rakić, Anđelija Malenović, Biljana Jančić-Stojanović

IKL-29 VALIDACIJA METODE TEČNE HROMATOGRAFIJE ZA ANALIZU PRAMIPEKSOLA I NJEGOVIH NEČISTOĆA VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR THE ANALYSIS OF PARMIPEXOLE AND ITS IMPURITIES Ana Vemić, Anđelija Malenović, Biljana Jančić-Stojanović

IKL-30 RAZVOJ I OPTIMIZACIJA RP–HPLC METODE ZA ODREĐIVANJE TORASEMIDA I NJEGOVIH NEČISTOĆA U TABLETAMA DEVELOPMENT AND OPTIMIZATION OF RP–HPLC METHOD FOR SIMULTANEOUS DETERMINATION OF TORASEMIDE AND ITS IMPURITIES IN TABLETS Žarko Jović, Ljiljana Živanović, Marija Malešević, Ana Protić

IKL-31 VAZODILATATORNI EFEKTI NOVOSINTETISANIH DERIVATA PROPAFENONA THE VASODILATATION EFFECTS OF NOVEL PROPAFENONE ANALOGS Branka Ivković, Ljiljana Gojković Bukarica, Bojan Marković, Sote Vladimirov

Page 27: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

IKL-32 ANALITIČKA POTVRDA ZLOUPOTREBE EFEDRINA KOD SPORTISTE PRIMENOM METODE TEČNE HROMATOGRAFIJE SA MS I DIODE ARRAY DETEKCIJOM: PRIKAZ SLUČAJA ANALYTICAL CONFIRMATION OF THE ABUSE OF EPHEDRINE IN ATHLETES USING THE METHOD OF LIQUID CHROMATOGRAPHY WITH PDA AND MS DETECTION: CASE REPORTS Gordana Brajković, Dragana Rančić, Olivera Potrebić, Vesna Kilibarda, Snežana Đorđević, Milica Zlatković

IKL-33 ODREĐIVANJE ROKSITROMICINA U URINU TEČNOM HROMATOGRAFIJOM SA UV SKENIRAJUĆIM DETEKTOROM DETERMINATION OF ROXITHROMYCIN IN HUMAN URINE BY LIQUID CHROMATOGRAPHY WITH PHOTO DIODE ARRAY DETECTION Snežana Đorđević, Branko Jovanović, Katica Drljević, Sonja Ćosić, Nadežda Krstić

IKL-34 MULTIKRITERIJUMSKI PRISTUP OPTIMIZACIJI HROMATOGRAFSKE METODE ZA PRAĆENJE STABILNOSTI MIKOFENOLAT MOFETILA MULTICRITERIA OPTIMIZATION APPROACH IN DEVELOPMENT OF STABILITY- INDICATING CHROMATOGRAPHIC METHOD FOR THE ANALYSIS OF MYCOPHENOLATE MOFETIL Ana Protić, Ljiljana Živanović, Mira Zečević, Biljana Otašević

IKL-35 VALIDACIJA SPE-HPLC-UV METODE ZA ANALIZU KARBAMAZEPINA I NJEGOVA DVA METABOLITA, KARBAMAZEPIN EPOKSIDA I KARBAMAZEPIN TRANS-DIOLA, U PLAZMI PACIJENATA OBOLELIH OD EPILEPSIJE VALIDATION OF SPE-HPLC-UV METHOD FOR ANALYSIS OF CARBAMAZEPINE AND ITS TWO METABOLITES, CARBAMAZEPINE EPOXIDE AND CARBAMAZEPINE TRANS-DIOL IN PLASMA OF EPILEPTIC PATIENTS Predrag Džodić, Ljiljana Živanović, Ana Protić, Ivana Ivanović, Radmila Veličković-Radovanović

IKL-36 STUDIJE FORSIRANE DEGRADACIJE FORCED DEGRADATION STUDIES Marija Pavlović, Ljiljana Vojvodić, Danica Agbaba

IKL-37 RP HPLC ODREĐIVANJE KISELINSKIH KONSTANTI BETA-HIDROKSI-BETA- ARILALKANSKIH KISELINA KAO POTENCIJALNIH ANTIINFLAMATORNIH AGENASA RP-HPLC DETERMINATION OF DISSOCIATION CONSTANTS OF SOME NOVEL BETA-HYDROXY-BETA-ARYLALKANOIC ACIDS AS POTENTIAL ANTI-INFLAMMATORY AGENTS Jelena Savić, Nikolina Kljajić, Sanda Dilber, Sote Vladimirov, Ivan Juranić, Jasmina Brborić

IKL-38 ODREĐIVANJE KISELINSKIH KONSTANTI PIRIDIN - DIKARBONSKIH KISELINA DETERMINATION OF THE ACIDITY CONSTANTS OF PYRIDINE DICARBOXYLIC ACID Branka Dražić, Gordana Popović, Sanja Grgurić-Šipka, Živoslav Tešić, Ivanka Ivanović

Page 28: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

IKL-39 RACIONALNO DIZAJNIRANJE LEKOVA RATIONAL DRUG DESIGN Zorica Vujić, Mira Zečević, Milkica Crevar

IKL-40 ISPITIVANJE USLOVA ZA RP-HPLC ANALIZU MOKSONIDINA U PRISUSTVU NJEGOVIH NEČISTOĆA INVESTIGATION OF CONDITIONS FOR RP-HPLC ANALYSIS OF MOXONIDINE IN PRESENTS OF IT`S IMPURITIES Svetlana Milovanović, Mira Zečević, Biljana Otašević

IKL-41 RAZUMEVANJE UPOTREBE ANTIEPILEPTIČKIH LEKOVA U DEPRESIJI UNDERSTANDING THE USE OF ANTIEPILEPTIC DRUGS IN DEPRESSION Snežana Agatonović-Kuštrin, David Morton

IKL-42 KOEFICIJENT DEZINFEKCIONE AKTIVNOSTI RASTVORA ZA ANALIZU BAKTERICIDNE AKTIVNOSTI RAZLIČITIH RASTVORA ZA DEZINFEKCIJU DISINFECTION ACTIVITY COEFFICIENT OF SOLUTION IN STUDYING BACTERICIDAL ACTIVITIES ON DIFFERENT DISINFECTANT SOLUTIONS Biljana Gjorgjeska

IKL-43 EKSPERIMENTALNO PRAĆENJE KONDENZACIJE KETOPROFENA RASTVORENOG U ACETONITRILU EXPERIMENTAL EVIDENCE OF A SPONTANEOUS CONDENSATION OF KETOPROFEN DISSOLVED IN ACETONITRILE Mieczyslaw Sajewicz, Marcin. Leda, Monika Gontarska, Dorota Kronenbach, Etienne Berry, Irving.R. Epstein, Teresa Kowalska

IKL-44 EKSPERIMENTALNO PRAĆENJE SPONTANE KONDENZACIJE MLEČNE KISELINE RASTVORENE U ETANOLU I ACETONITRILU EXPERIMENTAL EVIDENCE OF A SPONTANEOUS CONDENSATION OF LACTIC ACID DISSOLVED IN AQUEOUS ETHANOL AND ACETONITRILE Mieczyslaw Sajewicz, Marcin Leda, Dorota Kronenbach, Monika Gontarska, Etienne Berry, Irving R. Epstein, Teresa Kowalska

IKL-45 EKSPERIMENTALNO PRAĆENJE SPONTANE KONDENZACIJE FENILGLICINA I BADEMOVE KISELINE U VODENOM RASTVORU EXPERIMENTAL EVIDENCE OF A SPONTANEOUS CONDENSATION OF PHENYLGLYCINE AND MANDELIC ACID IN ABIOTIC AQUEOUS MEDIA Mieczyslaw Sajewicz, Marcin Leda, Monika Gontarska, Dorota Kronenbach, Etienne Berry, Irving R. Epstein, Teresa Kowalska

IKL-46 DEKONVOLUCIJA KOMPLEKSA TG-DTG-PODATAKA:PRIMENA U FARMACEUTSKIM SISTEMIMA DECONVOLUTION OF COMPLEX TG-DTG DATA: APPLICATIONS IN PHARMACEUTICAL SYSTEMS Samuel K. Owusu-Ware, Babur Z. Chowdhry, Stephen A. Leharne, Milan D. Antonijević

Page 29: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

SEKCIJA ZA FARMAKOEKONOMIJU (FE) PHARMACOECONOMICS SECTION (FE)

FE-1 DIREKTNI MEDICINSKI TROŠKOVI PROFILAKTIČKE PRIMENE CEFUROKSIMA I CEFTRIAKSONA KOD ELEKTIVNIH HIRURŠKIH INTERVENCIJA THE DIRECT MEDICAL COST OF PROPHYLACTIC USE OF CEFUROXIME VERSUS CEFTRIAXONE IN ELECTIVE SURGICAL INTERVENTION Dragana Lakić, Milena Radmilović, Katarina Ilić, Ljiljana Tasić, Marija Milenković, Ivana Tadić, Marina Petrić

FE-2 KOMPARATIVNA ANALIZA POTROŠNJE INSULINA U OPŠTINI BITOLA TOKOM 2007/2008. GODINE COMPARATIVE ANALYSIS OF THE CONSUMPTION OF INSULINS IN BITOLA DURING Slavica Jurukovska, Elena Jurukovska, Čedomir Dimitrovski

FE-3 ABC ANALIZA TROŠKOVA ZA LEKOVE U DOMU ZDRAVLJA NOVI SAD ABC ANALYSIS OF DRUG EXPENDITURE IN HEALTH CENTER NOVI SAD Božana Nikolić, Ana Pilipović, Mladena Lalić

FE-4 TRENDOVI UPOTREBE LEKOVA - INJEKCIJA U DOMU ZDRAVLJA NOVI SAD TRENDS IN USAGE OF INJECTION DRUGS IN HEALTH CENTER NOVI SAD Božana Nikolić, Ana Pilipović, Mladen Lalić

FE-5 ESENCIJALNA LISTA LIJEKOVA-OSNOV ZA FARMAKOPOLITIKU LIST OF ESSENTIAL MEDICINES – BASIS FOR PHARMACY POLICY Armin Škrbo, Ana Pantović

FE-6 ANALYSIS OF OUTPATIENT CONSUMPTION OF ORAL ANTIDIABETICS IN THE REPUBLIC OF SRPSKA, BOSNIA AND HERZEGOVINA Valentina Topić, Nebojša Mihajlica

FE-7 NARODNO LIJEČENJE KROZ HISTORIJU - KAO DIO FARMACIJE HISTORICAL FOLK'S CURE AS PART OF THE PHARMACY Armin Škrbo, Maida Piralić, Mijat Tuka

FE-8 RETAIL PHARMACY SERVICES - BRANDING SERVICES Svetlana Neceva, Rubin Zarevski

FE-9 WHO GOOD GOVERNANCE FOR MEDICINES PROGRAMME: MACEDONIAN EXPIRIENCES Renata Slaveska Raichki, Arta Kuli, Mihail Minov

FE-10 EVALUACIJA POTROŠNJE ANTIHIPERTENZIVA U REPUBLICI SRBIJI U PERIODU OD 2004-2008 EVALUATION OF ANTIHYPERTENSIVES CONSUMPTION IN THE REPUBLIC OF SERBIA FROM 2004-2008 Katarina Ilić, Danka Stefanović, Vesela Radonjić

Page 30: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

SEKCIJA ZA FARMACEUTSKU ZDRAVSTVENU ZAŠTITU – BOLNIČKA FARMACIJA (FZZ-BOL) PHARMACEUTICAL CARE – HOSPITAL PHARMACY SECTION (FZZ – BOL)

FZZ-BOL-1 ANALIZA BOLNIČKE POTROŠNJE LEKOVA ZA LEČENJE OSTEOPOROZE ANALYSIS OF HOSPITAL CONSUMPTION OF DRUGS IN TREATING OSTEOPOROSIS Aleksandra Kovačević, Aneta Perić, Maja Bojović

FZZ-BOL-2 ANALIZA BOLNIČKE POTROŠNJE ACE INHIBITORA I ANTAGONISTA RECEPTORA ANGIOTENZINA II ANALYSIS OF HOSPITAL CONSUMPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN II RECEPTOR ANTAGONISTS Aneta Perić, Maja Bojović

FZZ-BOL-3 PROCENA UTICAJA KOMBINOVANE TERAPIJE VALPROINSKOM KISELINOM ILI KARBAMAZEPINOM NA METABOLIZAM I FARMAKOKINETIKU MOKLOBEMIDA KOD DEPRESIVINIH BOLESNIKA THE EFFECTS OF COMBINATION THERAPY WITH VALPROIC ACID OR CARBAMAZEPINE ON MOCLOBEMIDE METABOLISM AND PHARMACOKINETICS IN DEPRESSIVE PATIENTS Anita Rakić Ignjatović, Branislava Miljković, Dejan Todorović, Ivana Timotijević, Milena Pokrajac

FZZ-BOL-4 PREDVIĐANJE KONCENTRACIJA SIROLIMUSA U PACIJENATA SA TRANSPLANTIRANIM BUBREGOM PRIMENOM VEŠTAČKIH NEURONSKIH MREŽA PREDICTION OF SIROLIMUS CONCENTRATIONS IN KIDNEY TRANSPLANT PATIENTS BY USING ARTIFICIAL NEURAL NETWORKS Bojana Perović, Jelena Petrović, Radmila Blagojević-Lazić, Dragana Radivojević-Đokić, Milica Prostran, Branislava Miljković

FZZ-BOL-5 FARMACEUTSKI OBLICI U TERAPIJI KARDIOVASKULARNIH OBOLJENJA: ASPEKTI AKTIVNOSTI KLINIČKOG FARMACEUTA DOSAGE FORMS OF CARDIOVASCULAR DRUGS: THE ASPECT OF THE ACTIVITIES OF CLINICAL PHARMACISTS Branka Brzaković, Gordana Vuleta, Branislava Miljković

FZZ-BOL-6 IZRADA UPUTSTVA ZA PRIPREMU I PRIMENU ANTIBIOTIKA PREPARING INSTRUCTIONS FOR THE PREPARATION AND USE OF ANTIBIOTICS Dijana Ribar

FZZ-BOL-7 ANTIBIOTICS POLICY AS A TOOL FOR OPTIMIZING THE HOSPITAL MEDICINES UTILIZATION Petrova Guenka, Assena Stoimenova, Manoela Manova, Alexandra Savova, Elena Arnaudova

FZZ-BOL-8 FARMAKOKINETIKA LIDOKAINA U PACIJENATA SA KARCINOMOM JETRE NAKON IZVOĐENJA LIDOKAINSKOG TESTA RADI PROCENE FUNKCIJE JETRE LIDOCAINE PHARMACOKINETICS IN PATIENTS WITH LIVER CARCINOMA AFTER LIDOCAINE TEST PERFORMANCE FOR LIVER FUNCTION EVALUATION Ivan Palibrk, Jelena Golubović, Jasna Bjelanović, Katarina Vučićević

Page 31: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

FZZ-BOL-9 EVALUACIJA SPONTANOG PRIJAVLJIVANJA NEŽELJENIH REAKCIJA NA LEKOVE U BOLNIČKOJ APOTECI U PERIODU JANUAR 2005- JUN 2010 EVALUATION OF ADVERSE DRUG REACTIONS (ADRs) REPORTING IN HOSPITAL PHARMACY IN THE PERIOD JANUARY 2005-JUNE 2010 Jasminka Dragić

FZZ-BOL-10 NAJČEŠĆI UZROČNICI URINARNIH INFEKCIJA U BOLNIČKIM USLOVIMA HOSPITAL ACQUIRED URINARY INFECTIONS Jelena Nikić, Nenad Miljković

FZZ-BOL-11 ANTIKOAGULANTNA KLINIKA VOĐENA OD STRANE FARMACEUTA U SRBIJI A PHARMACIST–LED ANTICOAGULATION CLINIC IN SERBIA Milica Ćulafić

FZZ-BOL-12 ULOGA BOLNIČKOG FARMACEUTA U ZDRAVSTVENOM TIMU POLIKLINIKE 25. UNIVERZIJADE - BEOGRAD 2009 ROLE OF HOSPITAL PHARMACIST IN POLYCLINIC HEALTH TEAM ON

TH 25 UNIVERSIADE - BELGRADE 2009 Mirjana Antunović, Jasmina Zečević, Dušica Mirković, Aneta Perić

FZZ-BOL-13 UPOREDNA STUDIJA INFEKCIJA IZAZVANIH MULTIREZISTENTNIM SOJEVIMA KOAGULAZA NEGATIVNOG STAFILOKOKA THE COMPARATIVE STUDY OF INFECTIONS CAUSED BY MULTIRESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCUS Nenad Miljković, Jelena Nikić

FZZ-BOL-14 LITIJUMOM PROUZROKOVANA ASIMPTOMATSKA HIPERKALEMIJA: PRIKAZ SLUČAJA A LITHIUM INDUCED ASYMPTOMATIC HYPERKALEMIA: CASE REPORT Tanja Radović, Aleksandra Todorović

FZZ-BOL-15 IMPLEMENTIRANJE CENTRALIZOVANE JEDINICE ZA PRIPREMU HEMOTERAPIJE U NAJVEĆU BOLNICU U REPUBLICI SRPSKOJ (BOSNA I HERCEGOVINA) IMPLEMENTING A CENTRALISED UNIT FOR CHEMOTHERAPY PREPARATION INTO THE LARGEST HOSPITAL IN THE REPUBLIC OF SRPSKA (BOSNIA AND HERZEGOVINA) Tijana Marinković

Page 32: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Poster prezentacije sekcija LB, FTK i TSHPoster presentations of sections LB, FTK and TSH

Prisustvo autora Presence of authors

Diskusija o odabranim poster prezentacijama sekcija LB, FTK i TSHDiscussion on poster presentations of sections LB, FTK and TSH

thSubota, 16. oktobar 2010. / Saturday, October 16 , 2010

09:00-18:00

12:00-13:00

13:00-13:30

SEKCIJA ZA LEKOVITO BILJE (LB) MEDICINAL PLANTS SECTION (LB)

LB-1 ANTIEDEMATOZNA I GASTROPROTEKTIVNA AKTIVNOST ULJANIH EKSTRAKATA VRSTE HYPERICUM RICHERI ANTI-EDEMATOUS AND GASTROPROTECTIVE ACTIVITY OF HYPERICUM RICHERI OIL EXTRACTS Gordana Zdunić, Dejan Gođevac, Marina Milenković, Katarina Šavikin, Nebojša Menković, Silvana Petrović

LB-2 ANTIEDEMATOZNA AKTIVNOST ETARSKIH ULJA IZ PODZEMNIH ORGANA LASERPITIUM ZERNYI HAYEK I CVASTI KAMILICE, MATRICARIA RECUTITA L. ANTI-EDEMATOUS ACTIVITY OF ESSENTIAL OILS FROM UNDERGROUND PARTS OF LASERPITIUM ZERNYI HAYEK AND FLOWERS OF MATRICARIA RECUTITA L. Višnja Popović, Ana Micov, Maja Tomić, Radica Stepanović-Petrović, Silvana Petrović

LB-3 ISPITIVANJE CITOTOKSIČNE I ANTIOKSIDANTNE AKTIVNOSTI EKSTRAKATA FERULA HEUFFELII GRISEB. EX HEUFFEL (APIACEAE) INVESTIGATION OF ANTIOXIDANT AND CYTOTOXIC ACTIVITY OF FERULA HEUFFELII GRISEB. EX HEUFFEL (APIACEAE) EXTRACTS Ivan Pavlović, Silvana Petrović, Zorica Juranić, Tatjana Stanojković, Jelena Kukić-Marković, Marjan Niketić

LB-4 ISPITIVANJE UTICAJA ETANOLNOG I METANOLNOG EKSTRAKTA VRSTE DICTAMNUS ALBUS NA VIABILNOST I PROLIFERACIJU HELA ĆELIJA EXAMINATION OF DICTAMNUS ALBUS LEAVES ETHANOL AND METHANOL EXSTRACTS ON HELA CELLS VIABILITY AND PROLIFERATION Dragana Pavlović, Marija Vukelić, Jelena Živanov-Čurlis, Dušanka Kitić, Bojan Zlatković, Stevo Najman

LB-5 ISPITIVANJE ANTIMIKROBNE AKTIVNOSTI EKSTRAKATA HERBE I RIZOMA PREVOLCA, EPIMEDIUM ALPINUM L. (BERBERIDACEAE) INVESTIGATION OF ANTIMICROBIAL ACTIVITY OF EPIMEDIUM ALPINUM L. (BERBERIDACEAE) HERB AND RHIZOME EXTRACT Zvezdana Došlov-Kokoruš, Marina Milenković, Nada Kovačević

Page 33: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

LB-6 ISPITIVANJE ANTIOKSIDANTNOG POTENCIJALA I FENOLNIH SASTOJAKA ALCHEMILLA VELEBITICA (BORBÁS EX JANCHEN) DEGEN (ROSACEAE) INVESTIGATION ON ANTIOXIDANT POTENTIAL AND PHENOLIC COMPOUNDS OF ALCHEMILLA VELEBITICA (BORBÁS EX JANCHEN) DEGEN (ROSACEAE) Jelena Kukić-Marković, Boško Bondžulić, Silvana Petrović, Marjan Niketić

LB-7 ANTIRADIKALSKA AKTIVNOST ACETONSKOG EKSTRAKTA SANGUISORBA OFFICINALIS L. (ROSACEAE) ANTIRADICAL ACTIVITY OF SANGUISORBA OFFICINALIS L. (ROSACEAE) ACETONE EXTRACT Jelena Kukić-Marković, Larisa Vujnović, Ivana Najdenov, Goran Janković

LB-8 HEMIJSKI SASTAV I ANTIMIKROBNA AKTIVNOST ETARSKIH ULJA VRSTA LASERPITIUM LATIFOLIUM L. I LASERPITIUM OCHRIDANUM MICEVSKI (APIACEAE) CHEMICAL COMPOSITION AND ANTIMICROBIAL ACTIVITY OF ESSENTIAL OILS OF LASERPITIUM LATIFOLIUM L. AND LASERPITIUM OCHRIDANUM MICEVSKI (APIACEAE) Višnja Popović, Silvana Petrović, Milica Pavlović-Drobac, Marina Milenković, Maria Couladis, Marjan Niketić

LB-9 HEMIJSKI SASTAV I ANTIMIKROBNA AKTIVNOST ETARSKOG ULJA ACHILLEA MULTIFIDA DC. (GRISEB) (COMPOSITAE) CHEMICAL COMPOSITION AND ANTIMICROBIAL ACTIVITY OF ACHILLEA MULTIFIDA DC. (GRISEB) (COMPOSITAE) ESSENTIAL OIL Milica Pavlović-Drobac, Silvana Petrović, Marina Milenković, Olga Tzakou, Marjan Niketić, Nada Kovačević

LB-10 SADRŽAJ I SASTAV ETARSKOG ULJA SALVIA OFFICINALIS L. (LAMIACEAE) U ZAVISNOSTI OD LOKALITETA I SEZONSKIH PROMENA CONTENT AND COMPOSITION OF ESSENTIAL OIL OF SALVIA OFFICINALIS L. (LAMIACEAE) DEPENDING ON LOCATION AND SEASONAL VARIATIONS Violeta Slavkovska, Mihailo Ristić, Branislava Lakušić, Dmitar Lakušić

LB-11 HEMIJSKI SASTAV ETARSKOG ULJA PLODA HERACLEUM PYRENAICUM LAM. SUBSP. POLLINIANUM (BERTOL.) PEDROTTI & PIGNATTI CHEMICAL COMPOSITION OF THE FRUIT ESSENTIAL OIL OF HERACLEUM PYRENAICUM LAM. SUBSP. POLLINIANUM (BERTOL.) PEDROTTI & PIGNATTI Milica Pavlović-Drobac, Silvana Petrović, Marjan Niketić

LB-12 HEMIJSKI SASTAV ISPARLJIVIH SUMPORNIH JEDINJENJA SAMONIKLIH PREDSTAVNIKA SEKCIJE ALLIUM (ALLIUM SP., SECT. ALLIUM) CHEMICAL COMPOSITION OF VOLATILE SULFUR COMPOUNDS IN WILD GROWING GARLICS (ALLIUM SP., SECT. ALLIUM) Biljana Božin, Dejan Orčić, Goran Anačkov, Bojan Zlatković, Nataša Simin, Neda Mimica-Dukić

LB-13 MASNE KISELINE IZ SEMENA PASTINACA HIRSUTA PANČIĆ (APIACEAE) SEED FATTY ACID COMPOSITION OF PASTINACA HIRSUTA PANČIĆ (APIACEAE) Peđa Janaćković, Vele Tešević, Nemanja Rajčević, Zoran Krivošej, Petar Marin

Page 34: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

LB-14 ODREĐIVANJE SADRŽAJA CINKA, BAKRA I HROMA U POJEDINIM VERONICA VRSTAMA (PLANTAGINACEAE) I UZORCIMA ZEMLJIŠTA SA RAZLIČITIH LOKALITETA U SRBIJI DETERMINATION OF ZN, CU AND CR IN SOME VERONICA SPECIES (PLANTAGINACEAE) AND SOIL SAMPLES FROM SEVERAL LOCATIONS IN SERBIA Jelena Živković, Zoran Maksimović, Jelena Arsenijević, Slavica Ražić

LB-15 ISPITIVANJE KVALITETA PROIZVODA SA KAMILICOM QUALITY STUDY OF PRODUCTS WITH CHAMOMILE Maja Mitrović, Branislava Lakušić, Nada Kovačević, Tatjana Kundaković

LB-16 PROCENA KVALITETA KOMERCIJALNIH ECHINACEA PROIZVODA U AUSTRALIJI QUALITY ASSESSMENT OF COMMERCIAL ECHINACEA PRODUCTS IN AUSTRALIA David Morton, Snežana Agatonović-Kuštrin

LB-17 A COMPARISON OF TRADITIONAL AND ALTERNATIVE FINGERPRINTING METHODS WITH ESSENTIAL OILS DERIVED FROM PLANT MATERIAL Mieczysław Sajewicz, Łukasz Wojtal, Maja Natić, Monika Waksmundzka-Hajnos, Teresa Kowalska

LB-18 A COMPARISON OF TRADITIONAL AND ALTERNATIVE FINGERPRINTING METHODS WITH PHENOLIC COMPOUNDS DERIVED FROM PLANT MATERIAL Mieczysław Sajewicz, Dorota Staszek, Łukasz Cieśla, Maja Natić, Monika Waksmundzka-Hajnos, Teresa Kowalska

LB-19 ISPITIVANJE ANTIINFLAMATORNOG DJELOVANJA MASTI SA SUVIM EKSTRAKTIMA RIZOMA I HERBE POTENTILLA RECTA L. (ROSACEAE) INVESTIGATION OF ANTI-INFLAMMATORY ACTIVITY OF OINTMENTS WITH DRY EXTRACTS OF RHIZOME AND HERB OF POTENTILLA RECTA L. (ROSACEAE) Saša Pilipović, Nedžad Mulabegović, Zakira Mornjaković, Alija Uzunović, Amar Elezović, Šeherzada Hadžidedić

LB-20 PRIMENA LEKOVITIH BILJAKA SA NAŠEG PODNEBLJA ZA UBLAŽAVANJE UPALNIH PROCESA NA KOŽI I SLUZOKOŽI USE OF MEDICINAL HERBS FROM OUR LOCALITIES FOR REDUCING INFLAMMATION OF SKIN AND MUCOUS MEMBRANE Jelena Svatok, Ljubinka Lemajić, Tatjana Kundaković, Nada Kovačević

LB-21 THIN-LAYER CHROMATOGRAPHY FOR FINGERPRINTING AND SCREENING THE BIOLOGICAL ACTIVITY OF PLANT EXTRACTS Monika Waksmundzka-Hajnos

LB-22 EFFECT OF IONIC LIQUID ADDITIVES TO MOBILE PHASE ON SEPARATION AND SYSTEM EFFICIENCY FOR HPLC OF SELECTED ALKALOIDS ON DIFFERENT STATIONARY PHASES Anna Petruczynik

Page 35: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

SEKCIJA ZA FARMACEUTSKU TEHNOLOGIJU I KOZMETOLOGIJU (FTK) PHARMACEUTICAL TECHNOLOGY AND COSMETOLOGY SECTION (FTK)

FTK-1 UTICAJ MOLARNOG ODNOSA SURFAKTANT/LEK NA ADSORPCIJU I OSLOBAĐANJE DIKLOFENAK NATRIJUMA IZ LEK-MODIFIKOVANI ZEOLIT KOMPOZITA THE INFLUENCE OF SURFACTANT/DRUG MOLAR RATIO ON ADSORPTION AND RELEASE OF DICLOFENAC SODIUM FROM DRUG-MODIFIED ZEOLITE COMPOSITES Danina Krajišnik, Jela Milić, Aleksandra Daković, Anđelija Malenović, Bojan Čalija

FTK-2 IZRADA I PROFILI OSLOBAĐANJA ALGINATNIH MIKROČESTICA OBLOŽENIH HITOZANOM I ALGINATNIH MIKROČESTICA PRIPREMLJENIH MEŠANJEM SA HPMC PREPARATION AND RELEASE PROFILES OF CHITOSAN-COATED AND HPMC-BLENDED ALGINATE MICROPARTICLES Nebojša Cekić, Jela Milić, Bojan Čalija, Snežana Savić, Miroslav Savić

FTK-3 LIPIDNE NANOČESTICE STABILIZOVANE POLIGLICEROLSKIM ESTRIMA MASNIH KISELINA: FIZIČKA STABILNOST I OKLUZIVNE OSOBINE POLYGLYCEROL FATTY ACID ESTER BASED LIPID NANOPARTICLES: PHYSICAL STABILITY AND OCCLUSIVE PROPERTIES Anđelka Kovačević, Snežana Savić, Gordana Vuleta, Jela Milić, Cornelia Keck, Rainer Helmut Müller

FTK-4 FORMULACIJA I ISPITIVANJE STABILNOSTI LIPIDNIH NANOČESTICA SA TAKROLIMUSOM FORMULATION AND STABILITY INVESTIGATION ON TACROLIMUS - LOADED LIPID NANOPARTICLES Anđelka Kovačević, Snežana Savić, Gordana Vuleta, Jela Milić, Cornelia Keck, Rainer Helmut Müller

FTK-5 FORMULATION AND EVALUATION OF SILICA BASED XEROGEL MICROPARTICLES FOR COLON DELIVERY OF 5-FU Beti Djurdjic, Marija Dodov Glavas, Nikola Geskovski, Maja Simonoska Crcarevska, Vesna Petrovska, Katerina Goracinova

FTK-6 FIZIČKOHEMIJSKA KARAKTERIZACIJA HITOZAN-CA-ALGINATNIH MIKROČESTICA SA NAPROKSENOM IZRAĐENIH POSTUPKOM JONOTROPNOG GELIRANJA I POLIELEKTROLITNOG KOMPLEKSIRANJA PHYSICOCHEMICAL CHARACTERIZATION OF NAPROXEN LOADED CHITOSAN-CA-ALGINATE MICROPARTICLES PRODUCED BY IONOTROPIC GELATION AND POLYELECTROLYTE COMPLEXATION Bojan Čalija, Jela Milić, Nebojša Cekić, Snežana Savić

FTK-7 PHYSICO-CHEMICAL CHARACTERIZATION OF BIODEGRADABLE POLYMERIC NANOPARTICLES LOADED WITH CPT-11 Maja Simonoska Crcarevska, Marija Glavas Dodov, Sema Calis, Vesna Petrovska, Jasmina Tonic Ribarska, Katerina Goracinova

FTK-8 CHARACTERIZATION OF BUDESONIDE LOADED GLYCERIDE NANOPARTICLES COATED WITH NON-IONIC SURFACTANT Hristina Litovin, Katerina Goracinova, Maja S. Crcarevska, Nikola Geskovski, Sanja Ostojic, Marija D. Glavas

Page 36: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

FTK-9 CITOZAN-CALCIUM-ALGINATNE MIKROCESTICE SA L. CASEI; VITALNOST ZA VREME MIKROINKAPSULIRANJA I U SIMULIRANIM IN VIVO USLOVIMA VIABILITY OF L. CASEI DURING MICROENCAPSULATION IN CHITOSAN-CALCIUM-ALGINATE MICROPARTICLES AND IN SIMULATED IN VIVO CONDITIONS Tanja Petreska Ivanovska, Margita Dabevska-Kostoska, Nikola Geskovski, K. Smilkov, Emil Popovski, Lidija Petrusevska-Tozi, Kristina Mladenovska

FTK-10 NANOČESTICE NA BAZI UGLJENIKA-NOVI NOSAČI LEKOVA? CARBON NANOPARTICLES-NOVEL DRUG CARRIERS? Mirjana Đukić, Vesna Milovanović, Aleksandra Buha, Evica Antonijević, Ivana Stevanović, Milica Ninković

FTK-11 UTICAJ PRIMARNE AMBALAŽE NA FOTOSTABILNOST KARVILEKS TABLETA INFLUENCE OF PRIMARY PACKAGING ON PHOTOSTABILITY OF KARVILEKS TABLETS Valentina Marinković, Ivan Savić, Predrag Sibinović, Miroslav Milenković, Ivana Savić

FTK-12 MANUFACTURING PROCESS OPTIMIZATION OF ZOLPIDEM TABLETS Packa Antovska, Bosilka Stefanova, Filip Butikoski, Blagica Debarlieva, Sonja Ugarkovic

FTK-13 RAZVOJ FORMULACIJE I EVALUACIJA AMLODIPIN BESILAT TABLETA FORMULATION AND EVALUATION OF AMLODIPINE BESYLATE TABLETS Berina Pilipović, Midhat Vehabović, Ervina Hadžović, Selma Šehić, Vlado Mekinjić

FTK-14 IN VITRO I IN VIVO EVALUACIJA TRAMADOL KAPSULA IN VITRO AND IN VIVO EVALUATION OF TRAMADOL CAPSULES Midhat Vehabović, Berina Pilipović, Nermina Tvrtković, Aydın Erenmemisoglu, Wolfgang Martin, Ilker Kanzik

FTK-15 UTICAJ USLOVA SUŠENJA RASPRŠIVANJEM NA KARAKTERISTIKE PRAŠKOVA ISPITIVAN PRIMENOM EKSPERIMENTALNOG DIZAJNA INFLUENCE OF SPRAY DRYING CONDITIONS ON POWDER CHARACTERISTICS EXAMINED BY EXPERIMENTAL DESIGN Tijana Mihajlović, Aleksandar Mladenović, Svetlana Ibrić

FTK-16 GRANULACIJA TOPLJENJEM U UREĐAJU TIPA FLUIDIZIRAJUĆEG SISTEMA – METODA ZA MASKIRANJE GORKOG UKUSA PARACETAMOLA FLUIDIZED HOT MELT GRANULATION – APPROACH TO MASK THE BITTER TASTE OF PARACETAMOL Ivana Mašić, Aleksandra Stojković, Jelena Parojčić, Zorica Đurić

FTK-17 POREĐENJE METODA ZA ISPITIVANJE BRZINE RASTVARANJA GRANULA I TABLETA SA MODIFIKOVANIM OSLOBAĐANJEM PARACETAMOLA COMPARATIVE DISSOLUTION TESTING OF PARACETAMOL EXTENDED RELEASE GRANULES AND TABLETS USING DIFFERENT DISSOLUTION TEST APPARATUSES Aleksandra Stojković, Ivana Mašić, Jelena Parojčić, Zorica Đurić

Page 37: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

FTK-18 UTICAJ TIPA LAKTOZE NA KARAKTERISTIKE TABLETA SA TRENUTNIM OSLOBAĐANJEM KOJE SADRŽE ATIPIČNE ANTIPSIHOTIKE AN INVESTIGATION INTO THE INFLUENCE OF THE TYPE OF LACTOSE ON THE CARACTERISTICS OF IMMEDIATE-RELEASE TABLETS CONTAINING ATYPICAL ANTIPSYCHOTICS Marija Đokić, Jovana Božić, Aleksandar Pavlović

FTK-19 FUNKCIONALNOST EKSCIPIJENASA I ODGOVARAJUĆI REGULATORNI ZAHTEVI FUNCTIONALITY RELATED CHARACTERISTICS OF PHARMACEUTICAL EXCIPIENTS AND RELEVANT REGULATORY REQUIREMENTS Stana Ubavić

FTK-20 IN SILICO PREDVIĐANJE RESORPCIJE NIMESULIDA IZ TABLETA SA TRENUTNIM OSLOBAĐANJEM MECHANISTIC SIMULATION OF NIMESULIDE ABSORPTION FROM IR TABLETS Sandra Grbić, Jelena Parojčić, Zorica Đurić

FTK-21 KOMPARATIVNA IN VITRO/IN VIVO KARAKTERIZACIJA EMULZIONIH PODLOGA SA ALKIL POLIGLUKOZIDNIM EMULGATOROM KAO NOSAČA ZA DIKLOFENAK I KETOPROFEN COMPARATIVE IN VITRO/IN VIVO ASSESSMENT OF EMULSION VEHICLES BASED ON ALKYL POLYGLUCOSIDE EMULSIFIER AS DELIVERY SYSTEMS FOR DICLOFENAC AND KETOPROFEN Ivana Jakšić, Milica Lukić, Jela Milić, Rolf Daniels, Snežana Savić

FTK-22 KARAKTERIZACIJA U/V KREMOVA STABILIZOVANIH “PRIRODNIM” EMULGATOROM POLIGLICERIL-3 METILGLUKOZA DISTEARAT CHARACTERIZATION OF O/W CREAMS STABILIZED WITH NATURAL EMULSIFIER POLYGLYCERYL-3 METHYLGLUCOSE DISTEARATE Marija Golubović, Danina Krajišnik, Dragana Vasiljević

FTK-23 IN VITRO I IN VIVO PROCENA EMULZIJA SA SRUKTUROM TEČNIH KRISTALA KAO NOSAČA ZA DIKLOFENAK DIETILAMIN IN VITRO AND IN VIVO EVALUATION OF EMULSIONS WITH LAMELLAR LIQUID CRYSTALLINE STRUCTURE AS VEHICLES FOR DICLOFENAC DIETHYLAMINE Nada Vučinić Milanković, Snežana Savić, Gordana Vuleta, Slavica Vučinić

FTK-24 FORMULISANJE V/U EMULZIJE ZA NEGU SUVE KOŽE: OPTIMALNE REOLOŠKE I SENZORIJELNE KARAKTERISTIKE FORMULATING OF W/O EMULSION FOR DRY SKIN: OPTIMAL RHEOLOGICAL AND SENSORY CHARACTERISTICS Milica Lukić, Ivana Jakšić, Gordana Vuleta, Snežana Savić

FTK-25 FORMULACIJA I KARAKTERIZACIJA U/V KREMOVA ZA POSVETLJIVANJE HIPERPIGMENTACIJA KOŽE IZRAĐENIH SA NATRIJUM-ASKORBILFOSFATOM FORMULATION AND CHARACTERISATION OF O/W CREAMS CONTAINING SODIUM ASCORBYL PHOSPHATE AS SKIN HIPERPIGMENTATION LIGHTENING INGREDIENT Marijana Milosavljević, Dragana Vasiljević, Marija Primorac

Page 38: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

FTK-26 ZNAČAJ UPOTREBE ANTIOKSIDANASA U KOZMETIČKIM PROIZVODIMA NAMENJENIM ZA ZAŠTITU KOŽE OD UV ZRAČENJA THE IMPORTANCE OF ANTIOXIDANTS USAGE IN COSMETIC PRODUCTS DESIGNED FOR UV SKIN PROTECTION Bojana Vučelić, Nataša Živanović, Mirjana Tasić

FTK-27 ALKILPOLIGLUKOZIDNI VS. TRADICIONALNI POLIETILENGLIKOLNI EMULGATORI KAO STABILIZATORI EMULZIJA - FIZIČKOHEMIJSKA KARAKTERIZACIJA I INVITRO/IN VIVO ISPITIVANJE EFEKATA NA KOŽI ALKYLPOLYGLUCOSIDE VS. TRADITIONAL POLYETHYLENE GLYCOL EMULSIFIER- BASED EMULSIONS - PHYSICOCHEMICAL AND IN VITRO/IN VIVO SKIN PERFORMANCE INVESTIGATION Marija Tasić-Kostov, Milica Lukić, Gordana Vuleta, Snežana Savić

FTK-28 ISPITIVANJE ANTIIRITANTNOG I VLAŽEĆEG EFEKTA KREMA SA BILJNIM EKSTRAKTIMA NA VEŠTAČKI IRITIRANU KOŽU EVALUATION OF ANTIIRRITATING AND MOISTURIZING EFFECTS OF THE CREAM CONTAINING SELECTED HERB EXTRACTS ON SURFACTANT-IRRITATED SKIN Ivana Arsić, Vanja Tadić, Marija Tasić-Kostov, Vesna Savić, Nataša Blažević- Kamenov, Sofija Đorđević, Dušanka Runjaić-Antić

FTK-29 UTICAJ SADRŽAJA POLIETILENGLIKOLA 400 NA PERMEACIJU FLUKONAZOLA IZ FORMULACIJA LAKA ZA NOKTE KROZ MEMBRANU GOVEĐEG PAPKA INFLUENCE OF POLYETHYLENE GLYCOL 400 CONTENT ON PERMEATION OF FLUCONAZOLE FROM NAIL LACQUER FORMULATIONS THROUGH BOVINE HOOF MEMBRANE Alisa Elezović, Sabira Hadžović, Amar Elezović, Indira Mujezin, Jasmina Hadžiabdić, Ognjenka Rahić

FTK-30 UTICAJ TEHNOLOŠKOG POSTUPKA NA STRUKTURU NEJONSKE AMBIFILNE PODLOGE THE INFLUENCE OF PREPARATION МЕТHOD ON THE STRUCTURE OF NONIONIC AMPHIPHILIC COMPOSITION Marija Toskić-Radojičić, Miljana Golubović, Emilija Gazikalović, Mirjana Boškivić, Aleksandra Aranđelović

FTK-31 MAGISTRALNI LEKOVI SA UREOM, KALCIPOTRIOLOM I KOFEINOM U TERAPIJI PSORIJAZE I UTICAJ NA KVALITET ŽIVOTA PACIJENATA EXTEMPORARY PREPARED CREAMS CONTAINING UREA, CALCIPOTRIOL AND CAFFEINE IN THERAPY OF PSORIASIS AND IMPACT ON THE QUALITY OF LIFE OF PATIENTS WITH PSORIASIS Mirjana Gajdaš, Nataša Živanović, Filip Šer

FTK-32 EX TEMPORE PRIPREMA I ISPITIVANJE INJEKCIJA CEFUROKSIM-NATRIJUM 10 mg/ml EX TEMPORE PREPARATION AND QUALITY EVALUATION OF CEFUROXIM-SODIUM INJECTION 10 mg/ml Dragana Aleksić, Mirjana Antunović, Vesna Putić, Dušica Mirković, Sonja Ćosić, Vladimir Draganić

Page 39: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

FTK-33 A SURVEY ON BENZALKONIUM CHLORIDE ADSORPTION BY VARIOUS FILTER MEMBRANES FOR STERILE FILTRATION OF NAPHAZOLINE HYDROCHLORIDE EYE DROPS Dejan Kostovski, Sanja Simeonovska, Suzan Sejfulah, Irena Brashnarska, Sonja Ugarkovic

FTK-34 FORMULACIJA I KARAKTERIZACIJA KAPI ZA OČI SA CIKLOSPORINOM A PRIPREMLJENIH EX TEMPORE IZ KOMERCIJALNIH PREPARATA FORMULATION AND CHARACTERIZATION OF CYCLOSPORINE A EYE DROPS PREPARED EXTEMPORANEOUSLY FROM CYCLOSPORINE A COMMERCIAL PRODUCTS Ljiljana Đekić, Jela Milić, Jasmina Drašković, Danina Krajišnik, Marija Primorac

FTK-35 FORMULACIJA I KARAKTERIZACIJA KAPI ZA UŠI SA ETARSKIM ULJEM EUKALIPTUSA FORMULATION AND CHARACTERIZATION OF EAR DROPS WITH ESSENTIAL EUCALYPTUS OIL Slavica Milic, Jela Milic, Petar Milic, Niko Radulovic, Zoran Todorovic, Valentina Arsic-Arsenijevic

FTK-36 UPRAVLJANJE PROJEKTOM VALIDACIJE FARMACEUTSKIH PROCESA U APOTECI BEOGRAD Studija slučaja: IZRADA ERITROMICIN RASTVORA ZA PRIMENU NA KOŽI PHARMACEUTICAL PROCESSES VALIDATION PROJECT MANAGEMENT IN THE "BELGRADE" COMMUNITY PHARMACY. Case study: PREPARATION OF ERYTHROMYCIN TOPICAL SOLUTION Nataša Živanović, Mirjana Gajdaš, Milanka Vico-Stevanović

FTK-37 AKT O KATEGORIJI PROIZVODA KOJI SE IZDAJU U APOTEKAMA – ZAŠTO GA NEMA U SRBIJI? THE ACT ON THE CATEGORY OF PRODUCTS THAT ARE ISSUED IN PHARMACIES - WHY DOES NOT EXIST IN SERBIA? Gordana Vuleta, Radava Korać, Iva Zdravković

FTK-38 PROIZVODNJA AKTIVNE SUPSTANCE – HUMANI ANTIRABIJSKI IMUNOGLOBULIN PRODUCTION OF ACTIVE SUBSTANCE – HUMAN ANTIRABIES IMMUNOGLOBULIN Dragica Vidanović, Branimir Kešin, Marina Sinđić Milićević, Nenad Vranješ, Verica Radovanović, Laura Balint

FTK-39 ISPITIVANJE FLUIDNOSTI MEMBRANA RAZLIČITIH INVASOMA PRIMENOM ELEKTRON-SPIN REZONANCE INVESTIGATION OF FLUIDITY OF DIFFERENT INVASOMES BY ELECTRON SPIN RESONANCE Nina Dragicevic-Curic, Manfred Friedrich, Danijela Pecarski, Winfried Plass, Alfred Fahr

Page 40: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

SEKCIJA ZA TOKSIKOLOŠKU I SANITARNU HEMIJU (TSH) TOXICOLOGICAL AND SANITARY CHEMISTRY SECTION (TSH)

TSH-1 PROFILAKTIČKI EFEKAT PRETRETMANA MAGNEZIJUMOM NA SADRŽAJ KADMIJUMA KOD MIŠEVA IZLOŽENIH AKUTNOM TROVANJU KADMIJUMOM PROPHYLACTIC EFFECT OF MAGNESIUM PRETREATMENT ON CADMIUM CONTENT IN MICE EXPOSED TO ACUTE CADMIUM INTOXICATION Danijela Djukic-Ćosić, Zorica Bulat, Milica Ninković, Predrag Vukomanović, Živorad Maličević, Vesna Matović

TSH-2 PROGRAM ZAŠTITE RADNE SREDINE OD UTICAJA ALKOHOLA I DRUGIH PSIHOAKTIVNIH SUPSTANCI PROTECTION PROGRAM OF OCCUPATIONAL ENVIRONMENT AGAINST ALCOHOL AND OTHER PSYCHOACTIVE SUBSTANCES Petra Milićević, Ana Vitković

TSH-3 ASSESSMENT OF HEAVY METAL LEVELS IN SERUM SAMPLES OF PROFESSIONALLY EXPOSED WORKERS Darinka Gjorgieva, Katarina Smilkov, Biljana Gjorgjeska

TSH-4 METAL CONTENT IN MEDICINAL PLANTS GROWING IN MACEDONIA Darinka Gjorgieva, Tatjana Kadifkova-Panovska, Katerina Baceva, Trajce Stafilov

TSH-5 MONITORING OF HEAVY METAL POLLUTION USING PLANT ASSAY Darinka Gjorgieva, Tatjana Kadifkova-Panovska, Katerina Bačeva, Trajče Stafilov

TSH-6 ZNAČAJ BIOLOŠKOG MONITORINGA THE IMPORTANCE OF BIOLOGICAL MONITORING Vladimir Nešić, Verica Uzelac

TSH-7 ODREĐIVANJE OPIJATA U SALIVI I URINU KOD AKUTNO OTROVANIH ZAVISNIKA DETERMINATION OF OPIATES IN SALIVA AND URINE IN ACUTELY POISONED PATIENTS Biljana Ćirić, Vesna Kilibarda, Dragan Stojšić, Jasna Jović-Stošić

TSH-8 KORELACIJE KONCETRACIJA DIAZEPAMA U SALIVI I SERUMU CORRELATION OF DIAZEPAM CONCENTRATIONS IN SALIVA AND SERUM Snežana Đorđević, Vesna Kilibarda, Slavica Vučinić, Biljana Antonijević, Ljubica Zamurović, Đorđe Ćurčić

TSH-9 TOKSIKOLOŠKO-HEMIJSKE ANALIZE BIOLOŠKOG MATERIJALA U ODELJENJU ZA TOKSIKOLOŠKU HEMIJU CENTRA ZA KONTROLU TROVANJA VMA U PERIODU OD 2006. DO 2009. TOXICOLOGICAL ANALYSIS OF BIOLOGICAL SAMPLES IN DEPARTMENT OF TOXICOLOGICAL CHEMISTRY POISON CONTROL CENTER MMA IN PERIOD FROM 2006. TO 2009. Snežana Đorđević, Gordana Brajković, Dragana Rančić, Dragan Stojšić, Milica Zlatković, Biljana Ćirić

Page 41: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

TSH-10 PRAĆENJE SADRŽAJA ARSENA U VODAMA ZA PIĆE SREMA I MAČVE U PERIODU 2004 - 2010. MONITORING OF ARSENIC IN DRINKING WATER OF SREM AND MACVA IN 2004 - 2010 Žaklina Ljubičić, Biljana Antonijević, Vesna Matović

TSH-11 MONITORING AFLATOKSINA B1 I OHRATOKSINA A U UZORCIMA NAMIRNICA MONITORING OF AFLATOXIN B1 AND OCHRATOXIN A IN FOOD SAMPLES Žaklina Ljubičić, Biljana Antonijević, Gorica Vuković, Marinela Tadić, Vesna Matović

TSH-12 ODREĐIVANJE ETANOLA U KRVI METODOM GASNE HROMATOGRAFIJE U ODELJENJU ZA TOKSIKOLOŠKU HEMIJU CENTRA ZA KONTROLU TROVANJA VMA DETERMINATION OF ETHANOL IN BLOOD BY GAS CHROMATOGRAPHY IN DEPARTMENT OF TOXICOLOGICAL CHEMISTRY POISON CONTROL CENTER MMA Dragana Rančić, Gordana Brajković, Milica Zlatković, Vesna Kilibarda, Snežana Đorđević, Nadežda Krstić

TSH-13 IDENTIFIKACIJA HEROINA U PREDMETIMA ZA SUDSKOMEDICINSKO VEŠTAČENJE U 2009 U ODELJENJU ZA TOKSIKOLOŠKU HEMIJU IDENTIFICATION OF HEROIN IN SAMPLES FOR FORENSIC EXPERTISE IN 2009 IN DEPARTMENT OF TOXICOLOGICAL CHEMISTRY Dragana Rančić

TSH-14 O TOKSIČNOSTI SIBUTRAMINA ABOUT THE TOXICITY OF SIBUTRAMINE Aleksandra Buha, Zorica Bulat, Predrag Vukomanović, Vesna Matović

TSH-15 SADRŽAJ FLUORIDA U INFUZIMA ZELENOG I CRNOG ČAJA KOJI SE NALAZE NA TRŽIŠTU SRBIJE FLUORIDE CONTENT IN TEA INFUSIONS AVAILABLE ON THE SERBIAN MARKET Aleksandra Repić, Vesna Milutinović, Zorica Blagojević, Biljana Antonijević, Zorica Bulat,Vesna Matović

TSH-16 DA LI PRIMENA MAGNEZIJUMA ILI CINKA UTIČE NA APSORPCIJU I ELIMINACIJU KADMIJUMA KOD KUNIĆA TROVANIH KADMIJUMOM? DOES MAGNESIUM OR ZINC SUPPLEMENTATION CHANGE CADMIUM ABSORPTION AND ELIMINATION IN RABBITS INTOXICATED WITH CADMIUM? Zorica Bulat, Danijela Đukić-Ćosić, Petar Bulat, Zoran Pavlović, Dragana Vujanović, Vesna Matović

TSH-17 SADRŽAJ FLUORIDA U ZUBIMA PACOVA IZLOŽENIH RAZLIČITIM KONCENTRACIJAMA FLUORIDA PUTEM VODE ZA PIĆE TEETH FLUORIDE LEVELS IN RATS EXPOSED TO DIFFERENT CONCENTRATIONS OF FLUORIDE IN DRINKING WATER Zoran Mandinić, Marijana Ćurčić, Biljana Antonijević, Momir Carević, Vesna Jaćević

TSH-18 PROCENA NEDELJNOG UNOSA ODREĐENIH KONTAMINANATA PUTEM RIBE ESTIMATION OF WEEKLY INTAKE OF CERTAIN CONTAMINANTS BY FISH CONSUMPTION Saša Janković, Tatjana Radičević, Slavica Vesković, Marijana Ćurčić, Ksenija Durgo, Biljana Antonijević

Page 42: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

TSH-19 OLOVO I ARSEN U DUVANU I GEOGRAFSKO POREKLO LEAD AND ARSENIC IN TOBACCO AND GEOGRAPHICAL ORIGIN Biljana Ljubenović, Jelena Videnović

TSH-20 PREDLOŽENA METODA ZA ANALIZU PREKURSORA I LEKOVA KOJI SE ZLOUPOTREBLJAVAJU IZ EKSTRAKTA PUNE KRVI PROPOSED METHOD FOR SCREENING OF PRECURSORS AND DRUGS OF ABUSE FROM WHOLE BLOOD EXTRACT Katarina Vučićević-Prčetić, Sebastian Kujundžić

TSH-21 PSIHOAKTIVNE SUPSTANCE KAO UZROK SMRTI: PODACI INSTITUTA ZA SUDSKU MEDICINU ZA PERIOD 2007-2009. GODINE PSYCHOACTIVE SUPSTANCES AS CAUSE OF DEATH: DATA REVIEW BY INSTITUTE OF FORENSIC MEDICINE, BELGRADE FOR PERIOD 2007-2009 Anđelka Spasić, Vera Lukić, Milena Spasić

TSH-22 ANALITIČKA POTVRDA ZLOUPOTREBE EFEDRINA KOD SPORTISTE PRIMENOM METODE TEČNE HROMATOGRAFIJE SA MS I PDA DETEKCIJOM: PRIKAZ SLUČAJA ANALYTICAL CONFIRMATION OF THE ABUSE OF EPHEDRINE IN ATHLETE USING THE METHOD OF LIQUID CHROMATOGRAPHY WITH PDA AND MS DETECTION: CASE REPORT Gordana Brajković, Dragana Rančić, Olivera Potrebić, Vesna Kilibarda, Snežana Đorđević, Milica Zlatković, Nadežda Krstić

TSH-23 STATUS UHRANJENOSTI I KOMPONENTE METABOLIČKOG SINDROMA U PACIJENATA NA TERAPIJI ATIPIČNIM ANTIPSIHOTICIMA NUTRITIONAL STATUS AND COMPONENTS OF METABOLIC SYNDROME IN PATIENTS ON ATYPICAL ANTIPSYCHOTICS THERAPY Bojana Vidović, Brižita Đorđević, Čedo Miljević, Dušica Lečić-Toševski, Nikola Milašinović, Ivanka Miletić

TSH-24 ODREĐIVANJE SADRŽAJA UKUPNIH POLIFENOLA U KOMERCIJALNIM PROIZVODIMA OD PLODA KAFE (COFFEA SP) I LISTA ČAJA (CAMELLIA SINENSIS) I NAPICIMA OD KAFE I LISTA ČAJA DETERMINATION OF TOTAL POLYPHENOLS IN COFFEE (COFFEA SP) AND TEA (CAMELLIA SINENSIS) PRODUCTS AND COFFEE AND TEA BEVERAGES Jelena Slavković, Slađana Šobajić, Tamara Milošević, Maja Pekić, Tatjana Kundaković

TSH-25 KORELACIJA UNOSA MLEKA I MLEČNIH PROIZVODA SA INDEKSOM TELESNE MASE U STUDENTSKOJ POPULACIJI ASSOCIATION BETWEEN TOTAL DAIRY INTAKE AND BMI IN STUDENT POPULATION Milica Ćulafić, Nevena Medaković, Sladjana Šobajić, Ivana Djuričić

TSH-26 UNOS DIJETNIH VLAKANA U ISHRANI PREDŠKOLSKE DECE: KOMPARACIJA ENZIMSKO-GRAVIMETRIJSKE I SCHARER-KURCHNEROVE METODE INTAKE OF DIETARY FIBERS WITHIN COLLECTIVE NUTRITION OF PRESCHOOL CHILDREN: ENZYME-GRAVIMETRIC AND SCHARER-KURCHNER - METHODS' COMPARISON Nataša Đukić, Slađana Šobajić, Ivanka Miletić, Gordana Vraštanović Pavićević

Page 43: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

TSH-27 SADRŽAJ SELENA U NAMIRNICAMA ŽIVOTINJSKOG POREKLA SELENIUM CONTENT IN FOOD OF ANIMAL ORIGIN Zoran Pavlović, Ivanka Miletić, Živan Jokić, Slađana Šobajić

TSH-28 REZISTENTAN SKROB I CELULOZA – NAJZNAČAJNIJA VLAKNA U PRAVILNO DIZAJNIRANOJ ISHRANI RESISTANT STARCH AND CELLULOSE - THE MOST IMPORTANT FIBER IN OPTIMALLY DESIGNED DIET Margarita Dodevska, Ivanka Miletić, Brižita Đorđević, Jelena Kotur-Stevuljević, Predrag Đorđević, Milan Simić

TSH-29 PROBIOTIČKE OSOBINE PRIRODNOG LACTOBACILLUS SP. IZOLATA HUMANOG POREKLA PROBIOTIC PROPERTIES OF THE NATURAL, HUMAN LACTOBACILLUS SP. ISOLATE Jelena Novaković Jovanović, Svetlana Seatović, Valentina Vranić, Zeljka Radulović, Gordana Zavišić

TSH-30 KONTROLA SADRŽAJA JODA U SOLI ZA LJUDSKU ISHRANU CONTROL OF SALT AS A SOURCE OF IODINE Konstansa Lazarević, Dejan Nikolic

TSH-31 ODREĐIVANJE SADRŽAJA KOENZIMA Q10 U UZORCIMA DIJETETSKIH SUPLEMENATA METODOM VISOKO-EFIKASNE TEČNE HROMATOGRAFIJE SA UV DETEKCIJOM DETERMINATION OF COENZYME Q10 IN DIETARY SUPPLEMENTS WITH HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH UV DETECTION Maja Mijačić, Milan Maksimović

TSH-32 ODREĐIVANJE TARTRAZINA, SUNSET YELLOW I AZORUBINA U INSTANT OSVEŽAVAJUĆIM BEZALKOHOLNIM PIĆIMA TANKOSLOJNOM HROMATOGRAFIJOM DETERMINATION OF TARTRAZINE, SUNSET YELLOW AND AZORUBINE IN INSTANT SOFT DRINKS BY THIN-LAYER CHROMATOGRAPHY Marija Stanković

TSH-33 ODREĐIVANJE UKUPNE SAPONIFIKUJUĆE MATERIJE U SAPUNIMA GRAVIMETRIJSKOM METODOM I POTENCIOMETRIJSKI DVOFAZNOM TITRACIJOM-POREĐENJE METODA COMPARATION OF DETERMINATION OF TOTAL FATTY MATTER IN SOAPS BY GRAVIMETRIC METHOD AND POTENTIOMETRIC TWO-PHASE TITRATION Ana Stanisavljev, Marija Stanković, Gorica Vuković, Marinela Tadić

TSH-34 ODREĐIVANJE SIBUTRAMINA U DIJETETSKIM PROIZVODIMA METODOM TEČNE HROMATOGRAFIJE TANDEM-MASENE SPEKTROMETRIJE (LC-MS/MS) DETERMINATION OF SIBUTRAMINE IN DIETARY PRODUCTS FROM SERBIAN MARKET BY LIQUID CHROMATOGRAPHY/TANDEM MASS SPECTROMETRY Gorica Vuković, Marinela Tadić, Marija Cindrić, Marija Stanković

TSH-35 ODREĐIVANJE SADRŽAJA SIBUTRAMINA U UZORCIMA DIJETETSKIH SUPLEMENATA ZELENE KAFE METODAMA VISOKO EFIKASNE TEČNE HROMATOGRAFIJE SA UV I MS DETEKCIJOM DETERMINATION OF SIBUTRAMINE CONTENT IN SOME DIETARY SUPPLEMENT SAMPLES WITH GREEN COFFEE EXTRACTS BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY WITH UV AND MASS SPECTROMETRY DETECTION Maja Mijačić, Milan Maksimović, Milica Zlatković

Page 44: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

TSH-36 ISPITIVANJE BIOSORBENTA ZA SPECIJACIONU ANALIZU HROMA IZ VODENIH RASTVORA EVALUATION OF BIOSORBENT FOR CHROMIUM SPECIATION ANALYSIS FROM AQUEOUS SOLUTIONS Anka Nedić, Danka Ristović, Brižita Đorđević, Katarina Karljiković-Rajić

TSH-37 ODREĐIVANJE OLOVA, ŽIVE I KADMIJUMA U RUŽEVIMA ZA USNE PORJEKLOM IZ KINE PRISUTNIM NA TRŽIŠTU BOSNE I HERCEGOVINE LEAD, MERCURY AND CADMIUM IN LIPSTICKS OF CHINESE ORIGIN PRESENT ON THE MARKET OF BOSNIA AND HERZEGOVINA Miroslav Šober, Elma Makarević, Amra Hrvat, Mirza Dedić, Jasmin Migalo, Saira Medanhodžić-Vuk

TSH-38 ANALIZA KAŠIRANIH I JEDNOSLOJNIH POLIMERNIH AMBALAŽNIH FOLIJA ZA ŽIVOTNE NAMIRNICE ANALYSIS OF LAYERED AND SINGLE-LAYERED POLYMER FOOD PACKAGING FOILS Marija Đorđević

TSH-39 SPEKTROFOTOMETRIJSKO ODREĐIVANJE ANTIOKSIDANTNIH OSOBINA IZABRANIH SORTI VINA SRBIJE SPECTROPHOTOMETRIC DETERMINATION OF ANTIOXIDATIVE CAPACITY OF SELECTED TYPES OF SERBIAN WINES Čakar Uroš, Čakar Nataša, Brižita Đorđević, Bojana Vidović

Page 45: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Mesto održavanja / Congress Venue

Page 46: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Izložba / Exibition

Page 47: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

OPSTE INFORMACIJE / GENERAL INFORMATION

Mesto odrzavanja / Venue

Sava centar / Congress Centre Sava13 - 17. oktobar 2010. / October 13 - 17, 2010www.savacentar.com

Zvanicni jezik / Official languages

Srpski i engleski / Serbian and EnglishPrevod nije obezbeden / Translation is not provided

Registracija ucesnika / Registration of participants Registracija ucesnika i dodatne informacije bice dostupne na Registracionom pultu u Kongresnom Centru Sava / Registration and information: Registration Desk, Sava Congress Center 13.10.2010. 14:00 - 19:0014.10.2010. 08:30 - 18:0015.10.2010. 08:30 - 18:0016.10.2010. 08:30 - 15:00

Bedzevi i ulaznice / Badges and entrance tickets

Prilikom registracije svaki ucesnik dobija finalni program, elektronsku verziju casopisa Arhiv za farmaciju i bedz koji je potrebno nositi u toku trajanja Kongresa. Prisustvo radnom delu i drugim kongresnim sadrzajima nece biti moguce bez bedza.Kotizacija za pratecu osobu ne ukljucuje kongresni materijal i potvrdu o ucescu.Every participant will receive the Final Programme, an electronic version of the Journal Arhiv za farmaciju and a Congress badge which should be worn during the Congress. Attendance to the working part and all other Congress events will not be possible without a badge. Registration fee for accompanying persons does not cover congress materials and certificate of attendance.

Izložba / Exhibition

Izložba farmaceutske industije i medicinske opreme biće otvorena za vreme trajanja naučnog dela Kongresa u holu ispred Plave dvorane.The exhibition of pharmaceutical and medical equipment will be opened during the scientific program in the exhibition area - in front of the Blue hall.

Page 48: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Tehničke mogućnosti / Technical support

U salama za rad su obezbeđeni tehnički uslovi za kompjutersku prezentaciju. Potrebno je da prezentacije budu pripremljene u programu MS Power Point i dostavljene na CD-u, USB memoriji ili na sopstvenom notebook računaru.Technical equipment for presentations is provided in working halls. Presentations in MS Power Point should be delivered on CD, USB memory or on own notebook.

Prezentacija radova / Types of presentation

Vreme za plenarna izlaganja je do 30 minuta.Vreme za predavanje po pozivu je od 20 do 30 minuta.Vreme za usmena izlaganja je do 15 minuta.Maksimalne dimenzije postera su 1m x 1.2 m. Posteri će biti izloženi u Sali/prostoru za poster prezentacije. Planirana je poster diskusija u okviru sekcija kao i dodela nagrada za najbolje poster radove.Plenary introductory lecture (30 minutes)Invited lecturers (20 -30 minutes)Oral presentation (10 -15 minutes)Poster persentation: max. dimension 1 m x 1.2 m. Posters will be displayed in the Posters hall. A poster discussion is planned within sections, followed by awards for the best posters.

Potvrda o učestvovanju / Certificates of attendance

Registrovani učesnici mogu podići potvrdu o učešću na registracionom pultu u subotu 16.10.2010. od 13:00h.Registered participants can collect Certificates of attendance at the Registration desk on Saturday, 16 October from 13:00h.

Page 49: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

DRUSTENI PROGRAM / SOCIAL PROGRAMME

Sreda / Wednesday 13. oktobar 2010. / October 13, 2010 - 18:00Plava dvorana Sava centra / Blue hall, Sava CenterSvečano otvaranje / Opening Ceremony

Petak / Friday

15. oktobar 2010. / October 15, 2010 - 20:30hPlava dvorana Sava centra/ Blue hall, Koncert Bilje Krstic/ Concert of Bilja KrsticAgencija za lekove i medicinska sredstva Srbije vas poziva na koncert koji ce odrzati Bilja Krstic i ansambl "Bistrik" Pozdravna rec: Mr. farm. spec. Tatjana Sipetic, direktorka Agencije za lekove i medicinska sredstva SrbijeThe Agency for Medicinal Products and Medical Devices of Serbia has the honour to invite you to the concert of Bilja Krstić and the "Bistrik" ensemble.Welcome word: by Mr. pharm. spec. Tatjana Šipetić, director of the Agency for Medicinal Products and Medical Devices of Serbia

Subota / Saturday

16. oktobar 2010. / October 16, 2010 - 20:00hSvecana vecera / Gala DinnerRestoran Sava / Restaurant SavaVauceri se preuzimaju prilikom registracije.Vouchers are issued at the Registration desk.

Ručak i kafe pauze / Lunch and coffee breaks Za vreme trajanja Kongresa učesnici sa plaćenom kotizacijom imaju pravo na 1 sendvič i 2 kafe dnevno, za koje će dobiti vaučere prilikom registracije.Kafa će se služiti 14, 15 i 16. oktobra od 10:00 -12:00 i od 16:00 -18:00 u Art café-uSendviči će se služiti 14, 15 i 16. oktobra od 13:00 -15:00 u Art café-u.Registered participants will receive at the Registration desk vouchers for 1 sandwich and 2 coffees per day to be used during the Congress.Coffee will be served on October 14, 15 and 16 from 10:00 -12:00h and 16:00 -18:00hin the ART Cafe.Sandwiches will be served on October 14, 15 and 16 from 13:00 -15:00h in the ART Cafe.

Sava Center

Page 50: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Smeštaj / Accommodation

Ucesnici Kongresa bice smesteni u sledecim hotelima:The participants of the Congress will be accommodated in following hotels:

HOTEL CONTINENTALVladimira Popovica 10, Novi BeogradTelefon: 220 4204

IN HOTELBul. Arsenija Carnojevica 56Telefon: 310 5354

MOSKVABalkanska 1, BeogradTelefon: 268 6255

PARKNjegoševa 4, BeogradTelefon: 364 0393

KASINATerazije 25, Beograd(centar, do Intercontinentala vozi autobus br. 95)Telefon: 323 5574

PALACETopličin venac 23, BeogradTelefon: 218 5585

Važne adrese / Important addresses

Naučni odbor, Organizacioni odbor, Sekretarijat KongresaThe Scientific Committee, the Organizing Committee,The Secretariate of the CongressFarmaceutsko društvo Srbije / Pharamceutical Society of Serbia11000 Beograd, Bulevar vojvode Mišića 25Telefon: +381 11 2648 385Faks: +381 11 2648 385e-mail: [email protected]

Izvršni organizatorExecutive organizerSmart TravelLicenca OTP 144/201011000 Beograd, Sv. Save 43/ITelefoni: +381 11 308 6694, 308 7487 Faks: +381 11 308 6695e-mail: [email protected]

Page 51: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

GALENIKA

Agencija za lekove i medicinska sredstva Srbije

PHARMANOVA

FARMALOGIST

A LEK

ACTAVIS

ALKALOID

BAYER

BEIERSDORF

BERLIN CHEMIE MENARINI

Boehringer Ingelheim Serbia

BONIFAR

BOSNALIJEK Predstavništvo Beograd

DR THEISS NATURWAREN

DRAGIS-PHARM

ELEPHANT PHARMA

Farmaceutska komora Srbije

GlaxoSmithKline

IVANČIĆ

Institut za proučavanje lekovitog bilja "Dr JOSIF PANČIĆ"

Jadran Galenski Laboratorij Rijeka

JAMAX M

JUGOHEMIJA FARMACIJA

KIBID

KIRKA CORPORATION

MCG GROUP

Predstavništvo MEDA Pharmaceuticals Switzerland GmbH

MERCK

MINISTARSTVO

MIP-PHARMA

MERCK SHARP&DOHME

SCHERING PLOUGH CENTRAL EAST AG

MULTIPHARM PLUS

NELT CO

NOBEL ILAC SANAZYII VE TICARET A.S.

NORDVIK

NYCOMED GmbH

PHARMASWISS

RICHTER GEDEON

SANDOZ PHARMACEUTICAL

SANOFI AVENTIS

SUPPLEMENT

SWISS HEALTH

ZAHVALJUJEMO NA POMOĆI U ORGANIZACIJI KONGRESA WE THANK FOR THE SUPPORT IN THE ORGANISATION OF THE CONGRESS

Page 52: Drage koleginice i kolege, - · PDF fileDrage koleginice i kolege, dragi prijatelji, Veliko je zadovoljstvo i privilegija poželeti Vam dobrodošlicu na V Kongres farmaceuta Srbije

Notes